<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
</journal-title-group>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28676848</article-id>
<article-id pub-id-type="pmc">5476750</article-id>
<article-id pub-id-type="doi">10.3389/fcimb.2017.00276</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tohidpour</surname>
<given-names>Abolghasem</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/429354/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morgun</surname>
<given-names>Andrey V.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/394473/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boitsova</surname>
<given-names>Elizaveta B.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/394651/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Malinovskaya</surname>
<given-names>Natalia A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/449557/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martynova</surname>
<given-names>Galina P.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khilazheva</surname>
<given-names>Elena D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kopylevich</surname>
<given-names>Natalia V.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gertsog</surname>
<given-names>Galina E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/296743/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Salmina</surname>
<given-names>Alla B.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/33156/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Research Institute of Molecular Medicine and Pathobiochemistry, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky</institution>
<country>Krasnoyarsk, Russia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Paediatrics, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky</institution>
<country>Krasnoyarsk, Russia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Children Infectious Diseases, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky</institution>
<country>Krasnoyarsk, Russia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ingar Olsen, University of Oslo, Norway</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Judith Miklossy, Prevention Alzheimer International Foundation, Switzerland; Frank C. Gibson III, University of Florida, United States; Alan Paul Hudson, Wayne State University School of Medicine, United States</p>
</fn>
<corresp id="fn001">*Correspondence: Abolghasem Tohidpour <email xlink:type="simple">a.tohidpour@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>7</volume>
<elocation-id>276</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>6</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Tohidpour, Morgun, Boitsova, Malinovskaya, Martynova, Khilazheva, Kopylevich, Gertsog and Salmina.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Tohidpour, Morgun, Boitsova, Malinovskaya, Martynova, Khilazheva, Kopylevich, Gertsog and Salmina</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Neuroinflammation is a complex inflammatory process in the central nervous system, which is sought to play an important defensive role against various pathogens, toxins or factors that induce neurodegeneration. The onset of neurodegenerative diseases and various microbial infections are counted as stimuli that can challenge the host immune system and trigger the development of neuroinflammation. The homeostatic nature of neuroinflammation is essential to maintain the neuroplasticity. Neuroinflammation is regulated by the activity of neuronal, glial, and endothelial cells within the neurovascular unit, which serves as a “platform” for the coordinated action of pro- and anti-inflammatory mechanisms. Production of inflammatory mediators (cytokines, chemokines, reactive oxygen species) by brain resident cells or cells migrating from the peripheral blood, results in the impairment of blood-brain barrier integrity, thereby further affecting the course of local inflammation. In this review, we analyzed the most recent data on the central nervous system inflammation and focused on major mechanisms of neurovascular unit dysfunction caused by neuroinflammation and infections.</p>
</abstract>
<kwd-group>
<kwd>infectious diseases</kwd>
<kwd>blood-brain barrier</kwd>
<kwd>immune response</kwd>
<kwd>neurodegeneration</kwd>
<kwd>brain development</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Russian Foundation for Basic Research<named-content content-type="fundref-id">10.13039/501100002261</named-content></funding-source>
<award-id rid="cn001">16-44-243073</award-id>
</award-group>
<award-group>
<funding-source id="cn002">President of Russian Federation</funding-source>
<award-id rid="cn002">10241.2016.7</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="211"></ref-count>
<page-count count="17"></page-count>
<word-count count="14756"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Upon confronting different stimuli such as infectious diseases, toxins, and traumatic shocks, the host cells present an orchestrated mechanism of actions to maintain the stability of body tissues. The innate immune cells (i.e., macrophages, dendritic, and mast cells) primarily interact with antigens in non-specific pathways and stimulate tissue homeostatic (inflammatory) responses (Medzhitov, <xref ref-type="bibr" rid="B120">2008</xref>). Some infectious agents can trigger intensive tissue inflammatory responses and activate the complement system. The inflammatory responses in the peripheral tissues cause dendritic cells to activate the adaptive immune system and induce some robust responses (i.e., necrosis as a result of phagocytosis). The tuned connection of the central nervous system (CNS)-immune system supports the host immune defense through various pathways such as inducing fever, pain sensitivity, and increasing the sleeping time (Maier et al., <xref ref-type="bibr" rid="B113">1998</xref>).</p>
<p>There are substantial differences between inflammatory responses arising from the CNS and other body tissues. Perhaps the main distinction is the lack of memory T cells (adaptive immunity) in the brain parenchyma. Memory T cells present the specific antigens of invading pathogens and leaving the CNS they enter lymph nodes and initiate cellular immune responses in lymphoid tissue. In the healthy brain, parenchymal T-cells are located in the cerebrospinal fluid (CSF) but in pathological conditions they enter the CNS through the choroid plexus and meningeal veins (Charo and Ransohoff, <xref ref-type="bibr" rid="B33">2006</xref>). These cells leave the CNS through the cribriform plate into the deep cervical lymph nodes (Andres et al., <xref ref-type="bibr" rid="B8">1987</xref>; Goldmann et al., <xref ref-type="bibr" rid="B69">2006</xref>; Ransohoff and Engelhardt, <xref ref-type="bibr" rid="B149">2012</xref>; Louveau et al., <xref ref-type="bibr" rid="B107">2015</xref>). On the other hand, B-cells, another group of adaptive immune cells, can enter the normal brain. However, their quantity and trafficking slightly increase after the outbreak of some pathologies such as AIDS (Anthony et al., <xref ref-type="bibr" rid="B9">2003</xref>). B-cells can differentiate to plasmoblasts and produce antibodies with different functions in the CNS or exert antibody-independent activities such as cytokine production and activation of T-cells (Ransohoff et al., <xref ref-type="bibr" rid="B151">2015</xref>). The brain parenchymal innate immune cells mainly consist of resident myeloid cells, astrocytes, and microglia, which enter the brain and spinal cord parenchyma during the early embryonic period (Sanes and Lichtman, <xref ref-type="bibr" rid="B163">1999</xref>; Del Rio and Feller, <xref ref-type="bibr" rid="B50">2006</xref>). Microglia are the key players in the physiological development of the brain (Schafer et al., <xref ref-type="bibr" rid="B167">2012</xref>). However, other cell populations within the CNS, such as astrocytes, myeloid cells, and dendritic cells also contribute to the functional activities and homeostasis of the brain (Chen and Regehr, <xref ref-type="bibr" rid="B34">2000</xref>; Ransohoff et al., <xref ref-type="bibr" rid="B151">2015</xref>).</p>
<p>It is clear that the impairment of blood-brain barrier (BBB) contributes to neuroinflammation. BBB and activated microglia are components of the neurovascular unit (NVU), and their structural and functional integrity is a major factor affecting the course of neuroinflammation. Migration of immune cells, transport of cytokines and other inflammatory reactions occur due to the increased permeability of BBB and dysfunction of NVU. Therefore, coordinated activity of NVU cells (brain microvessel endothelial cells, pericytes, perivascular astrocytes, neuronal cells, etc.) is necessary to regulate local inflammation in brain tissue. For instance, the integrated neuronal activity and the stimulation of astroglial cells (so-called neuron-astrocyte metabolic coupling) cause the accumulation of extracellular lactate and H<sup>+</sup> and affect the local inflammatory reactions in the brain. The increased level of neuronal activity also stimulates an inflammatory response in the peripheral tissues—so-called neurogenic inflammation (Figure <xref ref-type="fig" rid="F1">1</xref>; Roosterman et al., <xref ref-type="bibr" rid="B156">2006</xref>; Chiu et al., <xref ref-type="bibr" rid="B37">2012</xref>). Neurogenic inflammation often occurs due to pain, stress, and epileptic seizures and has a typical degree of similarity to other forms of CNS neuroinflammation (Zochodne et al., <xref ref-type="bibr" rid="B211">2001</xref>; Beggs et al., <xref ref-type="bibr" rid="B15">2010</xref>; Gruber-Schoffnegger et al., <xref ref-type="bibr" rid="B72">2013</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>The paradigm of the CNS neuroinflammation. Various factors can activate the immune response of the CNS and induce neuroinflammation. These stimuli are classified into two groups: 1—pathogen-associated molecular patterns (PAMPs), which are produced by the invading microorganisms of the CNS and 2—damage-associated molecular patterns (DAMPs), molecules that are released by host due to onset of traumatic conditions or interaction with some neurotransmitters (i.e., glutamate, GABA, and acetylcholine). The immune responses to the CNS stimuli vary based on the type of stimulation but generally lead to similar outcomes such as immune adaptation, dysfunction, degeneration, and resolution. Activation of the resting microglia and converting them to two distinct phenotypes depends on various cytokines produced by surrounding cells (glia, neurons, migratory immune cells). The release of interleukins 4 and 13 (IL-4, IL-13) gives rise to M1 phenotype (anti-inflammatory) of microglia, which express inflammatory cytokines (interleukin 4, 10, and 13), cell growth factors (i.e., NGF, BDNF, TGF-β, GDNF), and exert anti-inflammatory effects. Interferon-γ (IFN-γ) and the lipopolysaccharide (LPS) of bacteria, on the other hand, activate the M2 phenotype (pro-inflammatory) of microglia. The M2 phenotype is characterized by 1—activation of purinergic receptors P2X7 subtype (activated by ATP, promoting the inflammation and destruction of cells by forming channels and pores), and 2—expression of enzymes which generate reactive oxygen and nitrogen [NAD(P)H-oxidase, iNOS], and trigger the expression of proinflammatory cytokines (IL-1β, TNF-α, IL-6, IFN- γ). Activation of microglia, especially the formation of M2 phenotype exacerbates the damage to BBB (in particular neurons and endothelial cells). Effects of these agents (PAMPs, DAMPs, neuromediators) on astroglia cause their proliferation, activation (reactive astrogliosis), and dysfunction (in particular, increased procoagulant activity and thrombosis). These CNS stimuli also cause endothelial injury, damage, and neuronal death. GABA, γ-aminobutyric acid; IL, Interleukin; NGF, nerve growth factor; BDNF, brain-derived neurotrophic factor; TGF, transforming growth factor; GDNF, glial-derived neurotrophic factors; iNOS, inducible nitric oxide synthase; TNF, tumor necrosis factor; IFN, interferon; ROS, reactive oxygen species; NO, nitric oxide.</p>
</caption>
<graphic xlink:href="fcimb-07-00276-g0001"></graphic>
</fig>
<p>Taken together, neuroinflammation is a form of inflammatory response within the CNS, which is significantly affected by the status of neuronal activity and BBB permeability. Moderate inflammatory responses can protect the CNS whereas an intensive inflammation aggravates the impairment of tissue homeostasis (Combes et al., <xref ref-type="bibr" rid="B38">2012</xref>; Ransohoff and Brown, <xref ref-type="bibr" rid="B148">2012</xref>; Skaper et al., <xref ref-type="bibr" rid="B176">2012</xref>). In this review, we summarize the current knowledge on the role of BBB/NVU alterations in the development of neuroinflammation, with the emphasis on inflammatory processes caused by infectious diseases. Initially, an overview of physiologic development of NVU and BBB is made and we describe the main factors which modulate the development of neuroinflammation and other neurodegenerative disorders in the CNS. This is followed by discussing the impact of infectious diseases on inducing neuroinflammatory responses in the CNS. Finally, we unfold how neuroinflammation in the CNS is connected with genetic abnormalities of the host.</p>
</sec>
<sec id="s2">
<title>NVU/BBB development during the embryonic, fetal, and after-birth periods</title>
<p>BBB formation starts in the uterus and continues during the early postnatal period through several stages as 1-vascularization and angiogenesis (the formation of the choroid plexus and overgrowth of blood vessels); 2-differentiation of cerebral endothelial cells; and 3-the maturation of cellular elements of BBB (Engelhardt and Liebner, <xref ref-type="bibr" rid="B57">2014</xref>).</p>
<p>Vascularization and angiogenesis of BBB happen after the penetration of neuroblasts in the cranial area, where they form the perineural vascular plexus. This is followed by the proliferation of blood vessels from the perineural vascular plexus. The blood vessels grow radially into the neuroectodermal tissue and form multiple small spines that connect with the neighboring vessels. Throughout the prenatal period, vascularization is associated with the formation of a mature spatial structure and a peak of angiogenesis activity that remains stable until the early postnatal period (Ma et al., <xref ref-type="bibr" rid="B111">2012</xref>).</p>
<p>Unlike other tissues, CNS vascularization is exclusively driven by the angiogenesis. Different factors such as vascular endothelial growth factor (VEGF), angiopoietin-1, and sonic hedgehog protein (Shh) change the phenotype of endothelial cells of the perineural vascular plexus to blood vessels that sprout into the neural tube (Lippmann et al., <xref ref-type="bibr" rid="B103">2012</xref>). Differentiation of endothelial cells requires a basal membrane formed by various extracellular matrix proteins (collagen IV, fibronectin, and laminin-1). The coverage of the microvasculature by pericytes purposely determines them as the first neurovascular unit cells to physically interact with endothelial cells (Virgintino et al., <xref ref-type="bibr" rid="B197">2007</xref>). Pericytes, together with neighboring neural progenitor cells and radial glia might also influence the BBB development and induce barrier properties in the brain endothelial cells (Weidenfeller et al., <xref ref-type="bibr" rid="B202">2007</xref>; Daneman et al., <xref ref-type="bibr" rid="B43">2010b</xref>).</p>
<p>During the fetal period, endothelial cells acquire the phenotypic properties of specific tissues and inhabit areas of the developing brain, containing neuroepithelial cells, radial glia, neurons, and neuroblasts (Lippmann et al., <xref ref-type="bibr" rid="B103">2012</xref>). Immunophenotyping of endothelial progenitor cells showed that they express some key antigens markers such as CD31, CD34, and CD45 (Sukmawati and Tanaka, <xref ref-type="bibr" rid="B183">2015</xref>). Mobilization and collection of endothelial progenitor cells in the developing and mature brain are regulated by paracrine and endocrine signals that are produced by BBB. VEGF, Insulin-like growth factor-1 (IGF-1) and angiopoietin-2 are crucial for the mobilization of endothelial progenitor cells. During embryogenesis, endothelial cells retain the important function of regulating neurogenesis by maintaining a population of the brain stem and progenitor cells using growth factors such as brain-derived neurotrophic factor (BDNF), leukemia inhibitory factor (LIF), and Platelet-derived growth factor (PDGF). These processes also occur in the mature brain during the postnatal period (Urban and Guillemot, <xref ref-type="bibr" rid="B192">2014</xref>). In the embryonic brain, radial glial cells, and neuroepithelial cells interact with astrocytes and assist the maturation and maintenance of BBB. Several growth factors and signaling molecules such as angiopoietin-1, cyclic adenosine monophosphate, and basic fibroblast growth factor affect the BBB phenotype <italic>in vitro</italic>. It is clear that the BBB phenotype is influenced by the local microenvironment and is not intrinsic to brain endothelial cells themselves (Lippmann et al., <xref ref-type="bibr" rid="B102">2013</xref>).</p>
<p>Experiments on animal models (rodents) showed that BBB formation begins about 10 days after the embryonic development, followed by the expression of transporter molecules and tight junction proteins. BBB shows transendothelial resistance, which gradually increases during the early postnatal period and corresponds to the formation of full-fledged tight junctions (Siegenthaler et al., <xref ref-type="bibr" rid="B174">2013</xref>). In contrast to animal models, many fundamental features of human BBB development and maintenance remain unclear. After 5 weeks of gestation, the first vessels of the brain start to form as vesicles. During weeks 6–7, these vesicles develop to form a capillary coat in the ventricular zone (Budday et al., <xref ref-type="bibr" rid="B28">2015</xref>). After 15 weeks, the vessels penetrate radially through the nervous tissue and develop into collateral vessels with increased vascular density. During weeks 20–22, the growth of horizontal branches in the lower half of the cortex is detected. This phenomenon is followed by the growth of telencephalon microvessels and the expression of claudin 5 in endothelial cells (Norman and O'Kusky, <xref ref-type="bibr" rid="B134">1986</xref>; Virgintino et al., <xref ref-type="bibr" rid="B197">2007</xref>).</p>
<p>The final step of BBB development is maturation and formation of the NVU. These events are regulated by factors such as VEGF, death receptor 6 (DR6), and tumor necrosis factor receptor superfamily member 19 (TNFRSF19; Obermeier et al., <xref ref-type="bibr" rid="B136">2013</xref>). The neuroectodermal cells, perivascular astrocytes, and pericytes induce the expression of BBB-associated proteins in the brain endothelial cells, which in contact with neurons and glial cells form the BBB (Moretti et al., <xref ref-type="bibr" rid="B128">2015</xref>). BBB maturation in the postnatal period is determined by the formation of stable cell-to-cell interactions within the NVU (Daneman et al., <xref ref-type="bibr" rid="B42">2010a</xref>) and regulated by various humoral factors (i.e., hormones, cytokines, and neurotransmitters).</p>
</sec>
<sec id="s3">
<title>BBB alterations in neuroinflammation: molecular targets for inflammation-inducing stimuli</title>
<p>Microglia are the primary components of the CNS innate immune system. They produce cytokines and monitor the integrity of CNS. Microglia comprise about 5–20% of brain glial cell population (Sousa et al., <xref ref-type="bibr" rid="B179">2017</xref>) and are found both in the white and gray matter of the brain and spinal cord. Microglia develop early during the embryogenesis and then migrate to the CNS (Ginhoux et al., <xref ref-type="bibr" rid="B68">2010</xref>). The relatively small turnover of microglia makes them sensitive to the effect of inflammatory stimuli such as trauma, stress, and age (Ajami et al., <xref ref-type="bibr" rid="B3">2007</xref>; Ginhoux et al., <xref ref-type="bibr" rid="B68">2010</xref>). Microglia are crucial for surveying their microenvironment (Davalos et al., <xref ref-type="bibr" rid="B46">2005</xref>; Nimmerjahn et al., <xref ref-type="bibr" rid="B131">2005</xref>) and transporting the inflammatory signals (Dantzer et al., <xref ref-type="bibr" rid="B45">2008</xref>) to the CNS. Activated microglia respond to inflammatory signals by modifying their gene expression at the transcription level and releasing cytokines that assist in recruiting leukocytes to the CNS (Zhou et al., <xref ref-type="bibr" rid="B210">2006</xref>).</p>
<p>The regulation of neuroinflammatory responses is often a result of cooperation between different chemokines [such as chemokine (C-C motif) ligand 2 (CCL2), chemokine (C-C motif) ligand 5 (CCL5), and chemokine (C-X-C motif) ligand 1 (CXCL1)], cytokines (such as IL-6, and TNFα), reactive species of oxygen and secondary messengers (such as prostaglandins). Most of these factors are secreted by activated microglia, which support the synaptic connections and enhance the immunological responses of CNS (Norden and Godbout, <xref ref-type="bibr" rid="B133">2013</xref>; Schafer and Stevens, <xref ref-type="bibr" rid="B166">2013</xref>). Other resident cells of the CNS endothelium and macrophages are also crucial for modulating the inflammatory signals (Dunn et al., <xref ref-type="bibr" rid="B54">2006</xref>). Cytoskeletal rearrangement of activated microglia results in the modification of receptor patterns on their surface, which assist their migration to the source of inflammation (Russo and McGavern, <xref ref-type="bibr" rid="B158">2015</xref>) to represent their macrophage-like activity on the site of injury or infection (Davalos et al., <xref ref-type="bibr" rid="B46">2005</xref>). Therefore, the activated functions of microglia help to defend the CNS against the adverse effects of hostile threats while their over-activation might lead to some neuropsychiatric disorders such as depression (Norden and Godbout, <xref ref-type="bibr" rid="B133">2013</xref>).</p>
<p>Alzheimer's disease (AD) is an example of chronic neuroinflammatory disorder. AD is associated with the activation of microglia, infiltration of the brain tissue with peripheral immune cells, and misfolding and accumulation of several essential proteins (Walter et al., <xref ref-type="bibr" rid="B199">2007</xref>; Sokolova et al., <xref ref-type="bibr" rid="B178">2009</xref>). These phenomena can eventually cause neuronal damage and lead to death (Bucciantini et al., <xref ref-type="bibr" rid="B27">2002</xref>; Sokolova et al., <xref ref-type="bibr" rid="B178">2009</xref>). Unlike in other autoimmune inflammatory diseases, the brain is the initial site of accumulation of soluble β-amyloid and phosphorylated Tau proteins which lead to AD (Van Eldik et al., <xref ref-type="bibr" rid="B193">2016</xref>). Accumulation of β-amyloid causes cell toxicity, which might be counteracted by the expression of transporter molecules in the BBB to transfer the β-amyloid from the brain tissue to the blood. However, this mechanism appears to be affected in AD. Further, progression of neuroinflammation results in deposition of insoluble proteins aggregates, release of alarmins from the affected cells [i.e., HMGB1 (high mobility group box-1)] and elevated permeability of BBB leading to the migration of immune cells to the brain tissue. Alzheimer's type neurodegeneration and inflammatory responses greatly depend on metabolic alterations of neuronal and glial cells (i.e., impairment of neuron-astrocyte metabolic coupling, hypometabolism of glucose, glycolysis, and mitochondria-controlled metabolic changes in microglia) and disruption of calcium homeostasis in neuronal and astroglial cells. Such changes are linked to β-amyloid-induced hypervascularity (extensive angiogenesis) and hyperpermeability of newly-formed cerebral microvessels (Biron et al., <xref ref-type="bibr" rid="B17">2011</xref>). Accumulation of β-amyloid is also related to endothelial dysfunction, vasoconstriction and regional cerebral hypoperfusion of damaged cerebral vessels in AD (Thomas et al., <xref ref-type="bibr" rid="B187">1996</xref>; Niwa et al., <xref ref-type="bibr" rid="B132">2000</xref>; Suter et al., <xref ref-type="bibr" rid="B184">2002</xref>; Townsend et al., <xref ref-type="bibr" rid="B190">2002</xref>; Smith and Greenberg, <xref ref-type="bibr" rid="B177">2009</xref>). The local neuroinflammation in AD stimulates the impairment of BBB/NVU, while the loss of functional and structural integrity in the BBB promotes inflammatory alterations (Salmina et al., <xref ref-type="bibr" rid="B159">2010</xref>).</p>
<p>In addition to the chronic inflammation, CNS can be also affected by the so-called acute neurodegeneration, which is caused by various stimuli such as stroke, head injury, and cerebral or subarachnoid hemorrhage. Some of the markers of acute neurodegeneration are the release of certain chemokines and cytokines (i.e., TNFα, IL-1β, and IL-6), and the activity of microglia. The occurrence of acute neurodegeneration has positive impacts on the coordination of the CNS function to deal with the peripheral injuries or infections and improve the behavioral and physiological responses (Imeri and Opp, <xref ref-type="bibr" rid="B82">2009</xref>). During acute neurodegeneration, migration of the peripheral immune cells to the CNS is not significant, and no adverse effects such as cell atrophy or impairment of the BBB occur. It is therefore suggested that development of acute neurodegeneration assists the optimal local immune responses and provides the microenvironment that is necessary for brain recovery (Tarr et al., <xref ref-type="bibr" rid="B185">2014</xref>). However, acute neuroinflammation can also associate with excessive neuronal injury, BBB leakage, and neurological deficits that hamper neuronal regeneration and recovery.</p>
</sec>
<sec id="s4">
<title>Contradictory aspects of neuroinflammation</title>
<p>The close relationship between brain and spine injuries and development of neuroinflammation unveils a cascade of modulating events in affected hosts. CNS injuries activate microglia and astrocytes, release certain chemokines and cytokines and accelerate the migration of peripheral immune cells to the CNS (Werner and Engelhard, <xref ref-type="bibr" rid="B204">2007</xref>). They also cause edema, which is associated with elevated BBB permeability. Moreover, injuries to the CNS trigger post-traumatic symptoms with short-term inflammatory responses that can lead to long-term damages (David and Kroner, <xref ref-type="bibr" rid="B48">2011</xref>; Woodcock and Morganti-Kossmann, <xref ref-type="bibr" rid="B205">2013</xref>). The development of neuroinflammatory responses by the host immune system plays a dual role, which can be harmful or beneficial, depending on the type and extent of the stimulation. Damages to the CNS stimulate the inflammatory and repair responses of microglia and reveal their pro-inflammatory and neuroprotective roles, respectively.</p>
<p>The cytokine-mediated sickness behavior is an example of the positive effect of neuroinflammation. The sickness behavior is induced upon the activation of the immune system by various stimuli carried to the CNS. The corresponding inflammatory signal is processed in the NVU, brain stem, and circumventricular areas of the CNS (Laflamme et al., <xref ref-type="bibr" rid="B94">1999</xref>; Hansen et al., <xref ref-type="bibr" rid="B77">2001</xref>; Ching et al., <xref ref-type="bibr" rid="B36">2007</xref>) which produce cytokines such as IL-1β, TNF-α, and IL-6 (Henry et al., <xref ref-type="bibr" rid="B79">2009</xref>; Chen et al., <xref ref-type="bibr" rid="B35">2012</xref>). These chemical messengers connect the CNS to the immune system and stimulate the development of sickness behavior, which is defined by fever, hypophagia, lethargy, listlessness, and reduced social communications (Dantzer et al., <xref ref-type="bibr" rid="B45">2008</xref>). It is thought that the development of sickness behavior is evolutionarily necessary to counteract against life-threatening antigens and infections (Bluthe et al., <xref ref-type="bibr" rid="B18">2000</xref>; Berg et al., <xref ref-type="bibr" rid="B16">2004</xref>) without further losing the BBB integrity or transfer of peripheral immune cells to the CNS (Dantzer et al., <xref ref-type="bibr" rid="B45">2008</xref>).</p>
<p>Other positive effects of neuroinflammation are immune conditioning (dose-dependent stimulation of the peripheral immune system using bacterial cells; DiSabato et al., <xref ref-type="bibr" rid="B53">2016</xref>), developing the brain plasticity (stimulation of neurogenesis in the neurogenic niches), and assisting the repair process in the brain. On the other hand, some of the major negative impacts of neuroinflammation are injury-related hyperinflammatory responses, which trigger noradrenergic signaling (DiSabato et al., <xref ref-type="bibr" rid="B53">2016</xref>) and activate inflammasomes in the effector cells. These events accelerate the aging process of the brain by activating the immunologically challenged microglia.</p>
<p>Altogether, it can be concluded that the acute neuroinflammation is the positive and beneficial aspect of the CNS immune response whereas the chronic state of neuroinflammation is associated with brain damage and prolonged neurological deficits.</p>
</sec>
<sec id="s5">
<title>Association of infectious diseases with neuroinflammation</title>
<p>Activation of local inflammation often starts from the BBB endothelial cells equipped with the molecular machinery to sense bacterial and viral antigens. The first line of defense against microbial invasion comprises the antigenic recognition of a large group of conserved molecular determinants, called pathogen-associated molecular patterns (PAMPs; Hanke and Kielian, <xref ref-type="bibr" rid="B76">2011</xref>) by pattern recognition receptors (PRRs). The PRRs are located on the surface or within the cytoplasm of antigen presenting dendritic cells, macrophages, or other none-immune cells. PRRs activate the innate immune responses, trigger the phagocytic pathways and directly bind to the invading microorganisms. Toll-like receptors (TLRs) are essential PRRs, containing repeats of leucine residues on the N-terminus and a highly conserved C-terminal domain so-called Toll/interleukin (IL)-1 receptor (TIR). Expressed by glial cells and neurons, TLRs are necessary for priming the adaptive immune responses and inducing the release of co-stimulatory molecules and inflammatory cytokines (Hanke and Kielian, <xref ref-type="bibr" rid="B76">2011</xref>). TLRs also recognize a distinct group of host-derived molecules called danger associated molecular patterns (DAMPs), which are released upon the onset of diseases and infections that cause necrosis, apoptosis or tissue damage (Kirschning and Schumann, <xref ref-type="bibr" rid="B91">2002</xref>; Kaisho and Akira, <xref ref-type="bibr" rid="B88">2004</xref>; Kariko et al., <xref ref-type="bibr" rid="B89">2004</xref>; Piccinini and Midwood, <xref ref-type="bibr" rid="B143">2010</xref>; Hanke and Kielian, <xref ref-type="bibr" rid="B76">2011</xref>). The TLR-mediated DAMPs and PAMPs recognition is followed by forming an intracellular molecular machinery (inflammasome) for caspase-dependent processing of the cytokines (IL-1, IL-18). Expression of inflammasomes by the activated glial cells stimulate the brain-leukocyte infiltration (Alfonso-Loeches et al., <xref ref-type="bibr" rid="B5">2016</xref>). In particular, chronically elevated levels of IL-1 in brain tissue was shown to provoke BBB breakdown and neutrophil recruitment (Ferrari et al., <xref ref-type="bibr" rid="B59">2004</xref>). Therefore, measurement of IL-1 and IL-18 levels in the CSF seems like a useful tool to evaluate the severity of the neuroinflammation, i.e., in AD (Wang et al., <xref ref-type="bibr" rid="B200">2015</xref>).</p>
<p>The state of neurological and neurodegenerative diseases can be influenced by peripheral factors such as the gut microbiome (Dinan and Cryan, <xref ref-type="bibr" rid="B52">2015</xref>). Our gastrointestinal tract is perpetually covered with a population of microbial flora (Ley et al., <xref ref-type="bibr" rid="B98">2006</xref>) with the ability to cause significant impacts on the brain by releasing neurotransmitters, hormones, and neuropeptides (Selkrig et al., <xref ref-type="bibr" rid="B170">2014</xref>; Wall et al., <xref ref-type="bibr" rid="B198">2014</xref>). Some examples of these effects are neurodegenerative diseases, depression and autism spectrum disorder (ASD; Putignani, <xref ref-type="bibr" rid="B147">2012</xref>; Mayer et al., <xref ref-type="bibr" rid="B115">2014</xref>; Schroeder and Backhed, <xref ref-type="bibr" rid="B169">2016</xref>; Sharon et al., <xref ref-type="bibr" rid="B171">2016</xref>). Recent findings suggested that human microbiome can significantly affect brain function (Stilling et al., <xref ref-type="bibr" rid="B182">2014</xref>), development (O'Mahony et al., <xref ref-type="bibr" rid="B135">2017</xref>; Tognini, <xref ref-type="bibr" rid="B188">2017</xref>), and neuroinflammation (Rea et al., <xref ref-type="bibr" rid="B152">2016</xref>). The gut microbiota-BBB communication is evident since the gestation period: normal gut flora is required for BBB maturation, establishment of tight junctions, and BBB permeability (in mice; Braniste et al., <xref ref-type="bibr" rid="B21">2014</xref>). Alterations in the composition of normal flora is associated with severe neurological disorders which affect brain development, plasticity, and cause behavioral abnormalities (El Aidy et al., <xref ref-type="bibr" rid="B55">2014</xref>). Parkinson's disease (PD) is a multifactorial neurodegenerative disorder, which is associated with the accumulation of specific amyloid protein, called α-synuclein (α-Syn), a phenomenon that also occurs in other PD-related diseases such as multiple system atrophy (Brettschneider et al., <xref ref-type="bibr" rid="B23">2015</xref>; Sampson et al., <xref ref-type="bibr" rid="B160">2016</xref>). Patients with PD show significant gastric (intestinal) inflammation and majorly suffer from motor deficiencies. Study of a mouse model of Parkinson's disease suggested that the motor circuits dysfunctions are linked to the gastric tract abnormalities and highlighted the crucial role of gut microbial population in triggering the augmentation of α-Syn in PD (Sampson et al., <xref ref-type="bibr" rid="B160">2016</xref>). Host immune responses against infectious diseases are also involved in the pathogenesis of depression and ASD (Miller and Raison, <xref ref-type="bibr" rid="B124">2016</xref>). Several studies have pinpointed the association of aberrant neuroimmune responses with autism and development of depressive behavior (Buehler, <xref ref-type="bibr" rid="B29">2011</xref>; McCusker and Kelley, <xref ref-type="bibr" rid="B117">2013</xref>). In autism, neuroinflammation might occur in the intrauterine period of ontogenesis, and might further progress in the postnatal life in association with impaired angiogenesis and BBB hyperpermeability (Azmitia et al., <xref ref-type="bibr" rid="B11">2016</xref>). In autistic patients, the loss of BBB integrity is linked to the low expression of tight junction proteins and elevated permeability of their intestinal barrier (Fiorentino et al., <xref ref-type="bibr" rid="B61">2016</xref>). These findings suggest that intestinal microflora has a causative role in progression of autistic behavioral abnormalities (Diaz Heijtz, <xref ref-type="bibr" rid="B51">2016</xref>).</p>
<p>One of the most notorious infections of CNS is caused by <italic>Mycobacterium tuberculosis</italic>. Tuberculosis (TB) creates a typical pro-inflammatory response of host immune system (Lee et al., <xref ref-type="bibr" rid="B96">2009</xref>). The TB of CNS is probably the most severe type of tuberculosis and in most cases leads to death. Invasion of the CNS by <italic>M. tuberculosis</italic> is associated with formation of myddosome (see below), disruption of BBB due to cytoskeletal rearrangement in cerebral microvessel endothelial cells (Jain et al., <xref ref-type="bibr" rid="B85">2006</xref>; Cervantes, <xref ref-type="bibr" rid="B31">2017</xref>) and matrix metalloproteinase-mediated degradation of BBB (Green and Friedland, <xref ref-type="bibr" rid="B71">2007</xref>). Tumor necrosis factor (TNF) is a proinflammatory cytokine, which is involved in priming the host immune system against <italic>M. tuberculosis</italic> infection by activating the innate immunity and maintaining the granulomas structure. Investigation of the role of TNF in the immune response against TB of the CNS has shown its protective role. Those findings also proved that neurons are essential sources of TNF production to regulate the immune response against pathogens (Francisco et al., <xref ref-type="bibr" rid="B63">2015</xref>).</p>
<p>Some bacterial infections can develop neuroinflammation by altering the expression of endothelin-1 (ET-1; Freeman et al., <xref ref-type="bibr" rid="B64">2014</xref>). ET-1 is an isoform of endothelin, a short peptide with 21 amino acid residues, which is mainly expressed by endothelial cells. ET-1 is important for maintaining the vascular homeostasis (Agapitov and Haynes, <xref ref-type="bibr" rid="B1">2002</xref>; Schinelli, <xref ref-type="bibr" rid="B168">2006</xref>), vascular tone and inflammation (Speciale et al., <xref ref-type="bibr" rid="B180">1998</xref>; Bouallegue et al., <xref ref-type="bibr" rid="B19">2007</xref>; Kohan et al., <xref ref-type="bibr" rid="B92">2011</xref>). Different types of cells such as neurons, cardiomyocytes, and macrophages produce ET-1 (Freeman et al., <xref ref-type="bibr" rid="B64">2014</xref>). Although ET-1 is mainly a vasoconstrictor, it also acts as a pro-inflammatory cytokine, stimulates the aggregation of platelets and induces the expression of leukocyte adhesion molecules. ET-1 also stimulates the synthesis of inflammatory mediators that cause vascular dysfunction and lead to the progression of diseases and inflammation (Teder and Noble, <xref ref-type="bibr" rid="B186">2000</xref>). Several infectious diseases such as malaria (Dai et al., <xref ref-type="bibr" rid="B41">2012</xref>), infection of <italic>Rickettsia conorii</italic> (Davi et al., <xref ref-type="bibr" rid="B47">1995</xref>), and Chagas disease (Petkova et al., <xref ref-type="bibr" rid="B141">2001</xref>) are associated with ET-1 hyper-expression. These findings indicate the potential role of infectious diseases in developing neuroinflammation by activating ET-1 as a pro-inflammatory cytokine (Freeman et al., <xref ref-type="bibr" rid="B64">2014</xref>). Moreover, expression of ET-1 has been shown to increase in PD (Jain, <xref ref-type="bibr" rid="B84">2014</xref>) and AD (due to the activity of β-amyloid; Palmer et al., <xref ref-type="bibr" rid="B137">2012</xref>). Since overexpression of ET-1 in brain tissue mediates the breakdown of BBB (Zhang et al., <xref ref-type="bibr" rid="B209">2013</xref>), degenerative disorders seen in AD and PD could be, at least partially, caused by the ET-1 hyperexpression.</p>
<p>Taken together, it is crucial to maintain the normal status of body microflora (microbiome), which is necessary for the development of cerebral microvessel endothelial cells. Alterations in the microbiome might provoke inflammation-mediated BBB breakdown or aberrant maturation of newly established cerebral endothelial layer. If so, the association of chronic infections with NVU impairment seen in neurodegenerative or neurodevelopmental diseases is not surprising.</p>
</sec>
<sec id="s6">
<title>LPS: a key player in the development of the CNS neuroinflammation</title>
<p>Repeated and minimized contact with infectious agents such as bacterial cells or their constituents can activate the peripheral immune system, thus providing immune protection, in a unique way, which might not involve stimulation of neuroinflammatory responses in the CNS. This phenomenon is called euflammation (Tarr et al., <xref ref-type="bibr" rid="B185">2014</xref>; Liu et al., <xref ref-type="bibr" rid="B105">2016</xref>). Euflammation alters the innate immune system, through regulating the peripheral inflammatory kinetics and controls the receptors that bind to microbial antigens. It also down-regulates the production of pro-inflammatory cytokines, inhibits the activation of brain microglia, and minimizes the development of sickness behavior in animals that received bacterial cells or lipopolysaccharide (LPS; Tarr et al., <xref ref-type="bibr" rid="B185">2014</xref>). Therefore, euflammation can provide some immune protection against bacterial infections and severe toxicity by their endotoxins (Liu et al., <xref ref-type="bibr" rid="B105">2016</xref>).</p>
<p>LPS is a major component of the cell wall structure of gram-negative bacteria and a well-described endotoxin consisting of a polysaccharide chain (varies amongst different gram-negative bacteria) and lipid A (Alexander and Rietschel, <xref ref-type="bibr" rid="B4">2001</xref>). LPS endotoxins are used in modeling bacterial infections and stimulating the infection-associated inflammation via triggering TLR-4, a well-known receptor of LPS (Sandor and Buc, <xref ref-type="bibr" rid="B162">2005</xref>; Rosadini and Kagan, <xref ref-type="bibr" rid="B157">2017</xref>). The interaction of TLR4 with LPS triggers the formation of a macromolecular complex, so called myddosome (Rosadini and Kagan, <xref ref-type="bibr" rid="B157">2017</xref>), including several proteins such as myeloid differentiation primary response gene 88 (MyD88), TIR domain-containing adaptor protein (TIRAP), and interleukin-1 receptor-associated kinase-1 (IRAK). The myddosome complex stimulates the signaling pathways that activate NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), activation protein 1 (AP-1), and hyper-expression of several inflammatory genes (Rosadini and Kagan, <xref ref-type="bibr" rid="B157">2017</xref>). TLR4 also regulates other inflammatory responses, such as the release of mediatory microRNAs which sequester LPS-induced pro-inflammatory responses in order to minimize the tissue damage caused by LPS (Molteni et al., <xref ref-type="bibr" rid="B127">2016</xref>).</p>
<p>Nuclear binding domain NOD-like receptors (NLRs) are a main group of PRRs, which detect the bacterial cell wall components and trigger the inflammation. Nucleotide-binding oligomerization domain-containing proteins 1 and 2 (NOD-1 and NOD-2) are two major NLRs that detect bacterial peptidoglycan, induce the release of NF-κB and activate the mitogen-activated protein (MAP) kinase-dependant inflammatory responses (Elinav et al., <xref ref-type="bibr" rid="B56">2011</xref>). Studying the effects of NOD-1 and NOD-2 on brain activity of mice models showed that co-activation of NOD and TLR4 stimulated the peripheral immunity and intensified LPS-activated TLR4 impact on sickness behavior and brain function (Farzi et al., <xref ref-type="bibr" rid="B58">2015</xref>).</p>
<p>Furthermore, recent studies suggested that tolerance to LPS might trigger a late pro-inflammatory response and increase the expression of some anti-inflammatory cytokines that cause inimical injuries to the CNS (Pardon, <xref ref-type="bibr" rid="B138">2015</xref>). Frequent administration of LPS triggers the hyper-expression of IL-1β, TNF-α, and IL-12 in brain but reduces the systematic expression of cytokines. The occurrence of systemic infections increases the potential of brain innate immune cells to develop tolerance and may induce or aggravate the neurodegenerative process due to the damaging effect of cytokine hyper-production (Puntener et al., <xref ref-type="bibr" rid="B146">2012</xref>).</p>
<p>Epilepsy might be an example of an infection-mediated neuroinflammatory response, which contributes to the progression of chronic CNS disorders. Epilepsy is defined by the occurrence of unprovoked brain seizures and affected by a multitude of factors such as genetic background, CNS trauma, and infections (Vezzani and Granata, <xref ref-type="bibr" rid="B195">2005</xref>). Different infections from bacteria, viruses, fungi, parasites, and prions can stimulate the CNS inflammation and induce epileptic seizures (Vezzani et al., <xref ref-type="bibr" rid="B196">2016</xref>). Bacterial LPS can trigger epilepsy in mice and rat models through stimulating the secretion of cytokines, in particular, IL-1β, which is crucial in epileptogenesis (Auvin et al., <xref ref-type="bibr" rid="B10">2010</xref>). Administration of LPS into the peritoneal cavity of rats induces a cyclooxygenase-2 (COX-2) dependent inflammation. COX-2 is a prostanoid-forming enzyme, which is activated during seizures (Rojas et al., <xref ref-type="bibr" rid="B155">2014</xref>). The inducing effect of LPS on COX-2 indicates a higher seizure susceptibility and a more intense oxidative response during the LPS-mediated neuroinflammation (Ho et al., <xref ref-type="bibr" rid="B81">2015</xref>).</p>
<p>Lipoteichoic acid (LTA) is a main constituent of the cell wall structure which is found in gram-positive bacteria, consisting of polyhydroxy alkane repeats. LTA assists with bonding the bacteria to the microvascular endothelial cells of brain (Sheen et al., <xref ref-type="bibr" rid="B172">2010</xref>). Testing the LTA extracts on mice brain revealed that it simulated the release of interferon-γ (IFNγ), IL-6, and other cytokines. LTA was also associated with hyperexpression of circulating corticosterone and diminished expression of tight junction proteins, claudin 5 and occludin, in the brain (Mayerhofer et al., <xref ref-type="bibr" rid="B116">2017</xref>). Upon the onset of bacteriolysis in blood, i.e., as a result of antibiotic therapy, LTA is released and detected by TLR2. LTA-TLR-2 triggers the secretion of inflammatory cytokines such as TNF-α and IL-1b, which ultimately damage BBB (Boveri et al., <xref ref-type="bibr" rid="B20">2006</xref>).</p>
</sec>
<sec id="s7">
<title>The impact of infectious diseases on the incidence of neurodegenerative disorders</title>
<p>As mentioned above, several infectious agents could contribute to neuroinflammation and neurodegeneration. Recently, a group of pathogenic agents including <italic>Borrelia burgdorferi, Porphyromonas gingivalis, Chlamydophila pneumoniae, Helicobacter pylori</italic>, Cytomegalovirus, Herpes simplex virus type 1, Epstein-Bar virus, Human herpes virus 6, <italic>Candida glabrata</italic>, and <italic>Toxoplasma gondii</italic> have been addressed to have a significant effect on the late onset of AD in adults (LOAD; Bu et al., <xref ref-type="bibr" rid="B26">2015</xref>; Lim et al., <xref ref-type="bibr" rid="B100">2015</xref>; Figure <xref ref-type="fig" rid="F2">2</xref>). The late-age development of AD is purposely due to the activity of infections that initially occurred during the childhood (Khachaturian, <xref ref-type="bibr" rid="B90">1985</xref>). In AD, the association of chronic infections with progressive neurodegeneration was clearly demonstrated by recent studies (Maheshwari and Eslick, <xref ref-type="bibr" rid="B112">2015</xref>). Chronic spirochetal infections can induce β-amyloid accumulation in the brain, cause dementia and reproduce the clinical, pathological, and biological hallmarks of AD (Miklossy, <xref ref-type="bibr" rid="B121">2011</xref>). Thus, infections by spirochete bacteria have significant potentials in developing AD (De Chiara et al., <xref ref-type="bibr" rid="B49">2012</xref>; Hill et al., <xref ref-type="bibr" rid="B80">2014</xref>; Maheshwari and Eslick, <xref ref-type="bibr" rid="B112">2015</xref>). Different species of spirochetes, such as <italic>T. socranskii, T. pectinovorum, T. denticola, T. maltophilum, T. medium, T. amylovorum</italic>, and <italic>Borrelia burgdorferi</italic> (causing Lyme disease) are found in the brain of AD patients (Burgdorfer et al., <xref ref-type="bibr" rid="B30">1982</xref>; Riviere et al., <xref ref-type="bibr" rid="B153">2002</xref>). <italic>T. pallidum</italic> (the causative agent of syphilis) can reside in the brain and cause chronic infection which is associated with inflammation and dementia (Miklossy, <xref ref-type="bibr" rid="B122">2015</xref>). Moreover, infection by some spirochetes such as <italic>B. burgdorferi</italic> could trigger the formation of specific granulovacuolar lesions in neurons and glial cells, which are comparable to those found in AD (Miklossy et al., <xref ref-type="bibr" rid="B123">2006</xref>). AD patients are more vulnerable to infection-mediated cognitive impairment (McManus and Heneka, <xref ref-type="bibr" rid="B118">2017</xref>), particularly in the case of chronic respiratory tract infections (McManus et al., <xref ref-type="bibr" rid="B119">2014</xref>). Since β-amyloid shows antimicrobial properties <italic>in vitro</italic> (Welling et al., <xref ref-type="bibr" rid="B203">2015</xref>; Spitzer et al., <xref ref-type="bibr" rid="B181">2016</xref>), it is postulated that the excessive accumulation of β-amyloid in AD brain could reflect the response of brain neuronal cells to microbial agents. The co-morbidity of neurodegenerative and infectious diseases affects the progression of neurological disorders. For instance, the main cause of death in AD is the onset of infectious diseases such as pneumonia or urinary tract infections (Miklossy, <xref ref-type="bibr" rid="B122">2015</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Association of infectious agents with Alzheimer's disease. Chronic infections caused by major infectious agents, i.e., <italic>Helicobacter pylori</italic>, various types of spirochetes, including periodontal pathogen spirochetes and <italic>Borrelia burgdorferi, Porphyromonas gingivalis, Chlamydophila pneumoniae</italic>, Cytomegalovirus, Herpes simplex virus type 1, Epstein-Bar virus, Human herpes virus 6, <italic>Candida glabrata</italic> and <italic>Toxoplasma gondii</italic> are associated with development of AD. Early life exposure to these pathogenic agents can activate the resting microglia and astroglia, trigger the migration of immune cells to the neuro-endothelial tissue, degrade cell-cell tight junctions, and cause the breakdown of BBB. These activities result in development of various side effects such as neuronal damage, neuroinflammation and ultimately predispose the adult patient to develop AD.</p>
</caption>
<graphic xlink:href="fcimb-07-00276-g0002"></graphic>
</fig>
<p><italic>C. pneumoniae</italic> is an intracellular pathogenic bacterium which infects mucosal surfaces and causes respiratory infections such as community-acquired pneumonia (Grayston et al., <xref ref-type="bibr" rid="B70">1990</xref>). <italic>C. pneumoniae</italic> is suggestively associated with other non-respiratory malignancies such as inflammatory arthritis, multiple sclerosis, and AD (Balin et al., <xref ref-type="bibr" rid="B12">2008</xref>). The association of <italic>C. pneumoniae</italic> with pathogenesis of AD has been pinpointed in several studies (Balin et al., <xref ref-type="bibr" rid="B12">2008</xref>; Shima et al., <xref ref-type="bibr" rid="B173">2010</xref>). However, it is not still clear whether <italic>C. pneumoniae</italic> infection actually develops AD as there are some other studies which failed to show this relationship. Perhaps by utilizing a suitable <italic>C. pneumoniae</italic> infection model and applying standard methods which analyse homogenous sample analysis one would be able to elucidate this obscurity (Shima et al., <xref ref-type="bibr" rid="B173">2010</xref>).</p>
<p><italic>H. pylori</italic> is a gram-negative and spiral shaped bacterium that causes progressive and multistep inflammation of gastric lumen which, can lead to gastric cancer (adenocarcinoma; Tohidpour, <xref ref-type="bibr" rid="B189">2016</xref>). <italic>H. pylori</italic> infection has been linked to high risk of AD in infected patients. Analysis of rat models of <italic>H. pylori</italic> infection showed evidence of memory and spatial learning defects as well as damage to the maturation of hippocampus dendritic spine cells (Wang et al., <xref ref-type="bibr" rid="B201">2014</xref>). Such harmful effects are possibly exerted by soluble components of <italic>H. pylori</italic> surface fractions, which induce formation of Aβ42, a member of β-amyloid (Aβ) family, as main constituents of extracellular senile plaques (SP). Infection by <italic>H. pylori</italic> enhances the activity of γ-secretase, one of two enzymes, which process the amyloid precursor protein to produce mature Aβ, thus increasing levels of Aβ in brain of infected host and contributing to the development of AD (Wang et al., <xref ref-type="bibr" rid="B201">2014</xref>).</p>
</sec>
<sec id="s8">
<title>The relationship between viral infections and neuroinflammation in the CNS</title>
<p>The impact of viral infections on neuroinflammation develops through the interaction of CNS-associated immune responses with virulence factors of viruses, which trigger neurodegeneration and apoptosis in the brain (Amor et al., <xref ref-type="bibr" rid="B7">2010</xref>; Czirr and Wyss-Coray, <xref ref-type="bibr" rid="B39">2012</xref>). Viral encephalitis afflicts the CNS with various atrophies, such as loss of memory, acute CNS damage and death. The direct invasion of viruses to CNS can occur through at least five different pathways: (i) by tight junctions of brain microvascular endothelium; (ii) invading the brain microvascular endothelium and penetrating through the basolateral membranes; (iii) transfecting the migrating leukocytes to penetrate and infect the CNS; (iv) migrating through peripheral neuron to the CNS; and (v) infecting the olfactory bulb epithelium and migrating to the CNS (Miner and Diamond, <xref ref-type="bibr" rid="B125">2016</xref>). Microglia and astrocytes are two main types of cells, which are affected during viral infection of the CNS. They produce pro-inflammatory cytokines and various immune-mediator molecules that activate the immune system against viruses (Ransohoff and Perry, <xref ref-type="bibr" rid="B150">2009</xref>; Ransohoff and Brown, <xref ref-type="bibr" rid="B148">2012</xref>; Perry and Teeling, <xref ref-type="bibr" rid="B140">2013</xref>; Phares et al., <xref ref-type="bibr" rid="B142">2013</xref>).</p>
<p>Recognition of viral pathogenic molecular patterns by host PRRs stimulates different signaling pathways and activates transcription factors such as NF-κB and interferon regulatory factor 3 (IRF3). Activated IRF3 induces the expression of interferon β (INF-β), which exerts antiviral activity by inhibiting protein synthesis of viruses. Activated NF-κB triggers the release of some anti-apoptotic proteins and pro-inflammatory cytokines with significant antiviral effects (Santoro et al., <xref ref-type="bibr" rid="B164">2003</xref>; Vercammen et al., <xref ref-type="bibr" rid="B194">2008</xref>). Microglia and astrocytes have been shown to actively respond to both DNA and RNA viruses [i.e., vesicular stomatitis virus (VSV), cytomegaloviruses and Sendai virus] by releasing various types of proinflammatory cytokines and chemokines such as IL-1β, TNF-α, and IL-6 (Furr and Marriott, <xref ref-type="bibr" rid="B65">2012</xref>).</p>
<p>Viral infections also contribute to the development of AD. Viruses such as cytomegalovirus, herpesviridae, and herpes simplex type 1 (HSV-1) can escape the immune system and activate innate and adaptive immune responses via stimulating hyper-expression of pro-inflammatory cytokines with their DNA or RNA (Harris and Harris, <xref ref-type="bibr" rid="B78">2015</xref>). Viral infections either directly or indirectly contribute to AD pathogenesis through various pathways such as increasing the concentration of amyloids, phosphorylating certain neuronal proteins and afflicting neurons with injury. For instance, infections with cytomegaloviruses generate a systematic population of pro-inflammatory cytokines which can pass BBB, trigger the CNS neurodegeneration and lead to AD (Lim et al., <xref ref-type="bibr" rid="B100">2015</xref>). HSV-1 is usually found in the brain of infected adult hosts (Wozniak et al., <xref ref-type="bibr" rid="B206">2005</xref>) and is thought to be involved in development of AD in this group of patients (Agostini et al., <xref ref-type="bibr" rid="B2">2014</xref>). Primary infection with HSV-1 leads to persistent infection of sensory ganglion cells that belong to the peripheral nervous system. Various factors lead to activation of HSV-1 from the latency phase, such as stress and ultraviolet radiation (Itzhaki, <xref ref-type="bibr" rid="B83">2014</xref>). Re-activated HSV-1 affects the hippocampus as well as the frontal and temporal cortices of brain, which are also being affected in AD patients' brains. The immune system is also able to reactivate HSV-1 from latency. However, results of recent experiments have suggested a protective role of humoral immunity against the damaging effect of HSV-1 in the brain of infected patients (Mancuso et al., <xref ref-type="bibr" rid="B114">2014</xref>).</p>
<p>The ability of human immunodeficiency virus (HIV) type 1 to invade and infect the CNS is noteworthy. HIV can penetrate the CNS some weeks after the infection and induce a neuroinflammation pathway, which leads to the CNS injury (Schacker et al., <xref ref-type="bibr" rid="B165">1996</xref>; Pilcher et al., <xref ref-type="bibr" rid="B144">2001</xref>). It is thought that the CNS and the cerebrospinal fluid are potential niches for replication of HIV. The occurrence of genetic mutations in HIV genome leads to the evolution of HIV strains that evolve during early stages of infection and cause CNS inflammation and neurogenic damages (Dahiya et al., <xref ref-type="bibr" rid="B40">2013</xref>). Although the current strategies of anti-viral therapy have drastically reduced neurocognitive impairments caused by HIV, the overall occurrence of such injuries has increased. This increase is linked to the difficulties of accessing the anti-HIV treatments in developing countries. Previous experiments revealed that brain microvascular endothelial cells are crucial for the immunity of the CNS against HIV-mediated neuroinflammation. These cells recognize HIV molecular determinants using TLR3, release antiviral compounds such as INF-β and trigger the phosphorylation of IRF3 and IRF7, activities of which control the interferon signaling pathways and confer immune defense against HIV infection (Li et al., <xref ref-type="bibr" rid="B99">2013</xref>).</p>
<p>The neuroinflammatory disorders induced by West Nile virus (WNV) is another example of a viral infection-mediated CNS neurodegeneration. WNV is a mosquito-borne RNA virus belonging to flaviviruses (Lindenbach and Rice, <xref ref-type="bibr" rid="B101">2003</xref>). WNV is a major pathogen of the CNS neurons and causes viral encephalitis. Microglia and astrocytes of CNS are both infected with WNV and develop apoptosis (Yang et al., <xref ref-type="bibr" rid="B208">2002</xref>; Chambers and Diamond, <xref ref-type="bibr" rid="B32">2003</xref>). A large number of viral proteins, such as envelope and capsid proteins are involved in the neuropathogenesis of WNV (Beasley et al., <xref ref-type="bibr" rid="B13">2002</xref>, <xref ref-type="bibr" rid="B14">2005</xref>; Lee and Lobigs, <xref ref-type="bibr" rid="B95">2002</xref>). Amongst these, capsid proteins are the main viral factors causing neuroinflammation, neurotoxic effects, and apoptosis (Yang et al., <xref ref-type="bibr" rid="B208">2002</xref>). Upon infection with WNV, several PRRs including MDA5 (melanoma differentiation-associated protein 5), TLR3, TLR7, and RIG-I (retinoic acid-inducible gene 1) determine the molecular patterns of WNV. This recognition leads to hyperexpression of inflammatory cytokines such as IL-1 and TNF-α, which inhibit viral replication, enhance the presentation of viral antigens and increase the migration of leukocytes (to eradicate the WNVs from the CNS; Daniels et al., <xref ref-type="bibr" rid="B44">2014</xref>). Activation of PRRs by WNV also triggers the expression of IFN-α and IFN-β (type I INFs), which inhibit viral replication (Samuel and Diamond, <xref ref-type="bibr" rid="B161">2005</xref>) and enhance the capability of the adaptive immune system. <italic>In vitro</italic> studies on BBB models showed that the antiviral activities of type I IFNs regulate the permeability of brain endothelial cells and thus reduce viral movements across the BBB (Daniels et al., <xref ref-type="bibr" rid="B44">2014</xref>).</p>
<p>Two other members of flavivirus family, Zika virus (ZIKV) and Dengue virus are also linked to neuroinflammation of the CNS (Tsai et al., <xref ref-type="bibr" rid="B191">2016</xref>; Roach and Alcendor, <xref ref-type="bibr" rid="B154">2017</xref>). ZIKV, normally causes limited infections with symptoms such as fever, headaches, and conjunctivitis (Lum et al., <xref ref-type="bibr" rid="B108">2017</xref>). However, ZIKV is also associated with brain microcephaly and ocular defects in infants, which occur during the course of pregnancy (Roach and Alcendor, <xref ref-type="bibr" rid="B154">2017</xref>). Following recognition by TLR-3, infection of fetal brain cells with ZIKV impairs the neurosphere and brain organoid growth. ZIKV infection has been also found in Microglia and was shown to increase the level of cytokines such as IL-6, TNF-α, and IL-1β (Lum et al., <xref ref-type="bibr" rid="B108">2017</xref>). Same as WNV and ZIKV, Dengue is also a mosquito-borne RNA flavivirus. Globally, ~2.5 billion people are at risk of infection by Dengue virus (DENV; Guabiraba and Ryffel, <xref ref-type="bibr" rid="B73">2014</xref>). DENV infects around 400 million people each year causing symptoms such as fever, headache and rashes, which are referred as dengue fever stage. A minor proportion of patients who show the symptoms of the dengue fever further develop an acute form of disease called severe dengue haemorrhagic fever (DHF)/and shock syndrome (DSS). Some symptoms of DHF/DSS include gastrointestinal bleeding, renal/hepatic failure and hemorrhage which are determined by the interaction of viral virulence factors with components of host immune system. Strikingly, patients with DHF/DSS are very prone to neurological defects and CNS abnormalities. DENV can invade the CNS by transmitting though BBB and induce encephalitis (Tsai et al., <xref ref-type="bibr" rid="B191">2016</xref>).</p>
<p>Another example of a virus, which also causes encephalitis, is Chikungunya virus (CHIKV). CHIKV is a member of encephalitogenic RNA viruses and is transmitted by mosquito bites (Long et al., <xref ref-type="bibr" rid="B106">2013</xref>; Gerardin et al., <xref ref-type="bibr" rid="B67">2016</xref>). The infection of CHIKV causes debilitating rheumatic diseases and inflammatory disorders which are generally non-fatal. However, in rare cases CHIKV infection can cause neurodegenerative disorders such as meningoencephalitis, myelitis, and Guillain-Barre syndrome (Gerardin et al., <xref ref-type="bibr" rid="B67">2016</xref>; Brizzi, <xref ref-type="bibr" rid="B24">2017</xref>).</p>
<p>Taken together, the onset of viral infections in the CNS can induce neuroinflammation in the glial cells of NVU (Allen et al., <xref ref-type="bibr" rid="B6">2009</xref>; Kuang et al., <xref ref-type="bibr" rid="B93">2009</xref>) and activate host immune responses against the invading viral pathogens. Such immune responses might eventually result in elevated local cytokines/chemokines concentrations and loss of BBB integrity.</p>
</sec>
<sec id="s9">
<title>Role of host factors and genetic alterations in neuroinflammation</title>
<p>In addition to infectious agents and injuries, genetic mutations can also induce neuroinflammation. Genetic studies have elucidated the molecular mechanisms underlying the etiology and pathogenesis of various neurodegenerative disorders. Table <xref ref-type="table" rid="T1">1</xref> shows a list of some major immune genes whose mutations significantly induce different neurodegenerative diseases (Table <xref ref-type="table" rid="T1">1</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Immune genes associated with development of neurodegenerative diseases such as AD, encephalitis, and meningitis.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene/protein</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Localization</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Function/activity site</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Disease (references)</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TREM2 (TREM-2; Trem2a; Trem2b; Trem2c) (rs75932628-T)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chr 6: 41.16–41.16 Mb</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stimulation of the expression of inflammatory cytokines</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer's disease (Guerreiro et al., <xref ref-type="bibr" rid="B74">2013</xref>; Jiang et al., <xref ref-type="bibr" rid="B86">2013</xref>; Jonsson et al., <xref ref-type="bibr" rid="B87">2013</xref>; Pottier et al., <xref ref-type="bibr" rid="B145">2013</xref>)</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">APOE (AD2; LPG; APO-E; ApoE4; LDLCQ5)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chr 19</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulation of β-amyloid aggregation in the brain</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer's disease (Liu et al., <xref ref-type="bibr" rid="B104">2013</xref>)</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Genetic factor I (FI)</td>
<td align="left" colspan="1" rowspan="1" valign="top">I322T and D506V</td>
<td align="left" colspan="1" rowspan="1" valign="top">Complement factor I, A serine protease, regulating the immune response alternative pathway activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Recurrent aseptic meningo-encephalitis (Haerynck et al., <xref ref-type="bibr" rid="B75">2013</xref>)</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">CARD8 (NDPP; DACAR; DAKAR; NDPP1; TUCAN; CARDINAL) (rs2043211)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chr 19: 48.18–48.26 Mb</td>
<td align="left" colspan="1" rowspan="1" valign="top">An adaptor molecule, regulating apoptosis, NF-κB, and CASP1-dependent IL-1β</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pneumococcal meningitis (Geldhoff et al., <xref ref-type="bibr" rid="B66">2013</xref>)</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">NLRP1 (NAC; CARD7; CIDED; NALP1; SLEV1; DEFCAP; PP1044; VAMAS1; CLR17.1; DEFCAP-L/S) (rs11621270)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chr 19: 48.18–48.26 Mb</td>
<td align="left" colspan="1" rowspan="1" valign="top">Inducing apoptosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pneumococcal meningitis (Geldhoff et al., <xref ref-type="bibr" rid="B66">2013</xref>)</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">NFKBIE (IKBE) (rs3138053)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chr 6: 44.26–44.27 Mb</td>
<td align="left" colspan="1" rowspan="1" valign="top">Inhibition of NF-κB-mediated cellular hyper-expression</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pneumococcal meningitis (Lundbo et al., <xref ref-type="bibr" rid="B109">2016</xref>)</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">MBL2 (MBL; MBP; MBP1; MBPD; MBL2D; MBP-C; COLEC1; HSMBPC)</td>
<td align="left" colspan="1" rowspan="1" valign="top">10q21.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Member of the innate immune system. Activation of the classical complement pathway</td>
<td align="left" colspan="1" rowspan="1" valign="top">Meningococcal disease (Lundbo et al., <xref ref-type="bibr" rid="B110">2015</xref>)</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">LMP7 (JMP; ALDD; LMP7; NKJO; D6S216; PSMB5i; RING10; D6S216E)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chr 6: 32.84–32.84 Mb</td>
<td align="left" colspan="1" rowspan="1" valign="top">Low molecular weight proteasome, included in the class II major histocompatibility complex.</td>
<td align="left" colspan="1" rowspan="1" valign="top">LCMV-induced meningitis (Mundt et al., <xref ref-type="bibr" rid="B129">2016</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Acute hemorrhagic leukoencephalitis (AHLE) is a type of acute disseminated encephalitis that often leads to death. The etiology of AHLE is thought to be associated with upper respiratory infections, mumps, and infection by <italic>Mycoplasma pneumoniae</italic>. The deficit of complement factor I (CFI) is frequently associated with recurrent pyogenic infections such as meningitis and meningoencephalitis (Floret et al., <xref ref-type="bibr" rid="B62">1991</xref>; Leitao et al., <xref ref-type="bibr" rid="B97">1997</xref>). CFI is a regulator of the complement alternative pathway and a major complement inhibitor. Complete deficiency of CFI results in secondary complement deficiency due to uncontrolled and spontaneous alternative pathway activation, and leads to hyper-susceptibility to infections (Nilsson et al., <xref ref-type="bibr" rid="B130">2009</xref>). Broderick and co-workers described two pediatric AHLE patients of Filipino descent with partial CFI deficiency. They showed that the primary site of inflammation was in the CNS and reported symptoms such as headache, hallucinations, and reduced pupillary reaction to light. Physical examination of other patients showed that they had difficulties with speaking and suffered from fatigue. The authors identified two novel missense mutations in CFI by sequencing 13 exons of CFI and suggested that infections may trigger an uncontrolled activation of complement in brain parenchyma of predisposed individuals, leading to severe neuroinflammation and demyelination (Broderick et al., <xref ref-type="bibr" rid="B25">2013</xref>). Moreover, Haerynck and co-workers studied a rare deficiency of CFI in a patient with relapsing inflammatory-mediated meningoencephalitis. They described the case of a 16-year-old patient having headaches, nausea, vomiting, neck stiffness, diplopia, and lethargy as recurrent episodes of acute aseptic meningoencephalitis. MRI of brain further approved the evidence of meningoencephalitis. Mutation analysis of the complement factor I gene showed two heterozygous mutations (I322T and D506V) that resulted in a complete CFI deficiency due to a functional CFI defect (Haerynck et al., <xref ref-type="bibr" rid="B75">2013</xref>).</p>
<p>Clinical studies on the role of genetic abnormalities in pneumococcal meningitis showed the association of meningitis with polymorphisms in the inflammasome genes encoding caspase recruitment domain family member 8 (CARD8; SNP ID: rs2043211) and NLR family pyrin domain containing 1 (NLRP1; SNP ID: rs11621270). Genetic variations possibly influence inflammasome genes and alter the activation threshold of inflammatory responses (Geldhoff et al., <xref ref-type="bibr" rid="B66">2013</xref>). Furthermore, sequencing the coding regions of 46 innate immune genes from 435 patients, Ferwerda and co-workers showed that immune susceptibility to pneumococcal meningitis is related to variations in several genes encoding the CARD8, CXCL1, NOD-2, and interleukin-1 receptor-associated kinase 4 (IRAK4; Ferwerda et al., <xref ref-type="bibr" rid="B60">2016</xref>). Lundbo and co-workers also found the association of pneumococcal meningitis with the polymorphism of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor (NFKBIE) and that the increased risk of invasive pneumococcal disease (IPD) was in the heterozygosity meningitis group for NFKBIE (Lundbo et al., <xref ref-type="bibr" rid="B109">2016</xref>). Taken together, it is noteworthy to consider the impact of genetic variations and genetic abnormalities on function of certain genes, which are responsible for activity, protection, and homeostasis of NVU and the CNS. The onset of malignant mutations that disrupt the physiological functions of such genes can predispose the host to develop severe neurodegenerative disorders and/or manipulate the ability of immune system to defend against infectious agents invading the CNS.</p>
</sec>
<sec id="s10">
<title>Concluding remarks</title>
<p>Neuroinflammation in the CNS has two facets: one beneficial and the other destructive. It is not yet clear whether the onset of neuroinflammation is entirely useful or causes further damages. Moreover, the genetic background of host plays a critical role in predisposing the CNS to various neuroinflammatory responses and affecting the ability of the CNS to prevent neuropsychiatric and neurodegenerative disorders.</p>
<p>Microbial infections can trigger the CNS-associated immune responses and cause neurodegenerative and neurodevelopmental disorders. It is well-known that there is a complicated relationship between the host normal flora and the CNS. Majority of our understanding of the microbiome effects on the CNS homeostasis or disorders are derived from the microbiome-gut-brain axis. However, microbiome from other body niches might also be able to de-regulate the CNS and induce neuroinflammatory disorders. For instance, recent studies have found the presence of RNA of α-proteobacteria in human brain (Branton et al., <xref ref-type="bibr" rid="B22">2013</xref>). Some α-proteobacteria are known as pathogen of human, such as <italic>Rickettsia conorii, Rickettsia rickettsii</italic>, and <italic>Delftia acidovorans</italic> (in compromised patients) and/or have been isolated from cerebrospinal fluid (<italic>D. acidovorans</italic>; Pedersen et al., <xref ref-type="bibr" rid="B139">1970</xref>). It is therefore quite possible that such niche-specific microbiomes can directly engage components of host immune system (such as TLRs or NODs to activate brain immune signaling) and trigger neuroinflammation. Therefore, it seems crucial to further determine the effect of non-gut microbiome on homeostasis of the CNS and trafficking of immune constituents. It is practical to neutralize the severity of the CNS inflammation by antibiotic therapy of infections or eradication of inflammation-stimulating effector cells. However, these strategies are unable to guarantee lessening the excessive disadvantages of neuroinflammation or prevent psychological disorders such as mood or other degenerative diseases (Xanthos and Sandkuhler, <xref ref-type="bibr" rid="B207">2014</xref>). Alterations in normal composition of gut microflora can trigger some adverse brain disorders such as activation of hypothalamic pituitary adrenal (HPA) axis (Rea et al., <xref ref-type="bibr" rid="B152">2016</xref>), acute brain ischemia (Singh et al., <xref ref-type="bibr" rid="B175">2016</xref>), and neurodegeneration (Minter et al., <xref ref-type="bibr" rid="B126">2016</xref>). BBB serves as an essential mediator of the CNS-microbiome interactions. In this context, deciphering the mechanisms by which BBB is involved in pathogenesis of the CNS neuroinflammation sounds very important. It is therefore pivotal to further study the close relationship of host normal microbiome(s) and the CNS. This would provide a better understanding of the CNS-immune system interactions to improve the treatment of the CNS injuries and reduce the CNS susceptibility to infectious agents.</p>
</sec>
<sec id="s11">
<title>Author contributions</title>
<p>AT and AS wrote and edited the manuscript, and designed Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref> and Table <xref ref-type="table" rid="T1">1</xref>. AM and NM wrote the manuscript and designed Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref>. EB wrote the manuscript and designed Table <xref ref-type="table" rid="T1">1</xref>. NK, EK, GM, and GG wrote the manuscript.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>The study was supported by the grant #16-44-243073 provided by the RFBR and Krasnoyarsk Scientific Foundation (analysis of BBB impairment caused by infectious stimuli), and by the grant No. 10241.2016.7 of the President of Russian Federation given to Russian Leading Research Teams (analysis of neuroinflammation in chronic neurodegeneration).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agapitov</surname><given-names>A. V.</given-names></name><name><surname>Haynes</surname><given-names>W. G.</given-names></name></person-group> (<year>2002</year>). <article-title>Role of endothelin in cardiovascular disease</article-title>. <source/>J. Renin Angiotensin Aldosterone Syst.
<volume>3</volume>, <fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.3317/jraas.2002.001</pub-id><pub-id pub-id-type="pmid">11984741</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agostini</surname><given-names>S.</given-names></name><name><surname>Clerici</surname><given-names>M.</given-names></name><name><surname>Mancuso</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>How plausible is a link between HSV-1 infection and Alzheimer's disease?</article-title>
<source/>Expert Rev. Anti Infect. Ther.
<volume>12</volume>, <fpage>275</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1586/14787210.2014.887442</pub-id><pub-id pub-id-type="pmid">24502805</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajami</surname><given-names>B.</given-names></name><name><surname>Bennett</surname><given-names>J. L.</given-names></name><name><surname>Krieger</surname><given-names>C.</given-names></name><name><surname>Tetzlaff</surname><given-names>W.</given-names></name><name><surname>Rossi</surname><given-names>F. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Local self-renewal can sustain CNS microglia maintenance and function throughout adult life</article-title>. <source/>Nat. Neurosci.
<volume>10</volume>, <fpage>1538</fpage>–<lpage>1543</lpage>. <pub-id pub-id-type="doi">10.1038/nn2014</pub-id><pub-id pub-id-type="pmid">18026097</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>C.</given-names></name><name><surname>Rietschel</surname><given-names>E. T.</given-names></name></person-group> (<year>2001</year>). <article-title>Bacterial lipopolysaccharides and innate immunity</article-title>. <source/>J. Endotoxin Res.
<volume>7</volume>, <fpage>167</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1179/096805101101532675</pub-id><pub-id pub-id-type="pmid">11581570</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfonso-Loeches</surname><given-names>S.</given-names></name><name><surname>Ureña-Peralta</surname><given-names>J.</given-names></name><name><surname>Morillo-Bargues</surname><given-names>M. J.</given-names></name><name><surname>Gómez-Pinedo</surname><given-names>U.</given-names></name><name><surname>Guerri</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Ethanol-induced TLR4/NLRP3 neuroinflammatory response in microglial cells promotes leukocyte infiltration across the BBB</article-title>. <source/>Neurochem. Res.
<volume>41</volume>, <fpage>193</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-015-1760-5</pub-id><pub-id pub-id-type="pmid">26555554</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>I. C.</given-names></name><name><surname>Scull</surname><given-names>M. A.</given-names></name><name><surname>Moore</surname><given-names>C. B.</given-names></name><name><surname>Holl</surname><given-names>E. K.</given-names></name><name><surname>McElvania-TeKippe</surname><given-names>E.</given-names></name><name><surname>Taxman</surname><given-names>D. J.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>The NLRP3 inflammasome mediates <italic>in vivo</italic> innate immunity to Influenza A virus through recognition of viral RNA</article-title>. <source/>Immunity
<volume>30</volume>, <fpage>556</fpage>–<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2009.02.005</pub-id><pub-id pub-id-type="pmid">19362020</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amor</surname><given-names>S.</given-names></name><name><surname>Puentes</surname><given-names>F.</given-names></name><name><surname>Baker</surname><given-names>D.</given-names></name><name><surname>van der Valk</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Inflammation in neurodegenerative diseases</article-title>. <source/>Immunology
<volume>129</volume>, <fpage>154</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2567.2009.03225.x</pub-id><pub-id pub-id-type="pmid">20561356</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname><given-names>K. H.</given-names></name><name><surname>von During</surname><given-names>M.</given-names></name><name><surname>Muszynski</surname><given-names>K.</given-names></name><name><surname>Schmidt</surname><given-names>R. F.</given-names></name></person-group> (<year>1987</year>). <article-title>Nerve fibres and their terminals of the dura mater encephali of the rat</article-title>. <source/>Anat. Embryol.
<volume>175</volume>, <fpage>289</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1007/BF00309843</pub-id><pub-id pub-id-type="pmid">3826655</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>I. C.</given-names></name><name><surname>Crawford</surname><given-names>D. H.</given-names></name><name><surname>Bell</surname><given-names>J. E.</given-names></name></person-group> (<year>2003</year>). <article-title>B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas</article-title>. <source/>Brain
<volume>126</volume>, <fpage>1058</fpage>–<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awg118</pub-id><pub-id pub-id-type="pmid">12690046</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auvin</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>Mazarati</surname><given-names>A.</given-names></name><name><surname>Sankar</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA</article-title>. <source/>Epilepsia
<volume>51</volume>(<issue>Suppl. 3</issue>), <fpage>34</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02606.x</pub-id><pub-id pub-id-type="pmid">20618397</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azmitia</surname><given-names>E. C.</given-names></name><name><surname>Saccomano</surname><given-names>Z. T.</given-names></name><name><surname>Alzoobaee</surname><given-names>M. F.</given-names></name><name><surname>Boldrini</surname><given-names>M.</given-names></name><name><surname>Whitaker-Azmitia</surname><given-names>P. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Persistent angiogenesis in the autism brain: an immunocytochemical study of postmortem cortex, brainstem and cerebellum</article-title>. <source/>J. Autism Dev. Disord.
<volume>46</volume>, <fpage>1307</fpage>–<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-015-2672-6</pub-id><pub-id pub-id-type="pmid">26667147</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balin</surname><given-names>B. J.</given-names></name><name><surname>Little</surname><given-names>C. S.</given-names></name><name><surname>Hammond</surname><given-names>C. J.</given-names></name><name><surname>Appelt</surname><given-names>D. M.</given-names></name><name><surname>Whittum-Hudson</surname><given-names>J. A.</given-names></name><name><surname>Gerard</surname><given-names>H. C.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title><italic>Chlamydophila pneumoniae</italic> and the etiology of late-onset Alzheimer's disease</article-title>. <source/>J. Alzheimers. Dis.
<volume>13</volume>, <fpage>371</fpage>–<lpage>380</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2008-13403</pub-id><pub-id pub-id-type="pmid">18487846</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beasley</surname><given-names>D. W.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Suderman</surname><given-names>M. T.</given-names></name><name><surname>Barrett</surname><given-names>A. D.</given-names></name></person-group> (<year>2002</year>). <article-title>Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype</article-title>. <source/>Virology
<volume>296</volume>, <fpage>17</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1006/viro.2002.1372</pub-id><pub-id pub-id-type="pmid">12036314</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beasley</surname><given-names>D. W.</given-names></name><name><surname>Whiteman</surname><given-names>M. C.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>C. Y.</given-names></name><name><surname>Schneider</surname><given-names>B. S.</given-names></name><name><surname>Smith</surname><given-names>D. R.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains</article-title>. <source/>J. Virol.
<volume>79</volume>, <fpage>8339</fpage>–<lpage>8347</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.79.13.8339-8347.2005</pub-id><pub-id pub-id-type="pmid">15956579</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beggs</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>X. J.</given-names></name><name><surname>Kwan</surname><given-names>C.</given-names></name><name><surname>Salter</surname><given-names>M. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier</article-title>. <source/>Mol. Pain
<volume>6</volume>:<fpage>74</fpage>. <pub-id pub-id-type="doi">10.1186/1744-8069-6-74</pub-id><pub-id pub-id-type="pmid">21044346</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>B. M.</given-names></name><name><surname>Godbout</surname><given-names>J. P.</given-names></name><name><surname>Kelley</surname><given-names>K. W.</given-names></name><name><surname>Johnson</surname><given-names>R. W.</given-names></name></person-group> (<year>2004</year>). <article-title>α-tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice</article-title>. <source/>Brain Behav. Immun.
<volume>18</volume>, <fpage>149</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/S0889-1591(03)00113-2</pub-id><pub-id pub-id-type="pmid">14759592</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biron</surname><given-names>K. E.</given-names></name><name><surname>Dickstein</surname><given-names>D. L.</given-names></name><name><surname>Gopaul</surname><given-names>R.</given-names></name><name><surname>Jefferies</surname><given-names>W. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease</article-title>. <source/>PLoS ONE
<volume>6</volume>:<fpage>e23789</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0023789</pub-id><pub-id pub-id-type="pmid">21909359</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bluthe</surname><given-names>R. M.</given-names></name><name><surname>Laye</surname><given-names>S.</given-names></name><name><surname>Michaud</surname><given-names>B.</given-names></name><name><surname>Combe</surname><given-names>C.</given-names></name><name><surname>Dantzer</surname><given-names>R.</given-names></name><name><surname>Parnet</surname><given-names>P.</given-names></name></person-group> (<year>2000</year>). <article-title>Role of interleukin-1β and tumour necrosis factor-α in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice</article-title>. <source/>Eur. J. Neurosci.
<volume>12</volume>, <fpage>4447</fpage>–<lpage>4456</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2000.01348.x</pub-id><pub-id pub-id-type="pmid">11122355</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouallegue</surname><given-names>A.</given-names></name><name><surname>Daou</surname><given-names>G. B.</given-names></name><name><surname>Srivastava</surname><given-names>A. K.</given-names></name></person-group> (<year>2007</year>). <article-title>Endothelin-1-induced signaling pathways in vascular smooth muscle cells</article-title>. <source/>Curr. Vasc. Pharmacol.
<volume>5</volume>, <fpage>45</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.2174/157016107779317161</pub-id><pub-id pub-id-type="pmid">17266612</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boveri</surname><given-names>M.</given-names></name><name><surname>Kinsner</surname><given-names>A.</given-names></name><name><surname>Berezowski</surname><given-names>V.</given-names></name><name><surname>Lenfant</surname><given-names>A. M.</given-names></name><name><surname>Draing</surname><given-names>C.</given-names></name><name><surname>Cecchelli</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Highly purified lipoteichoic acid from gram-positive bacteria induces <italic>in vitro</italic> blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide</article-title>. <source/>Neuroscience
<volume>137</volume>, <fpage>1193</fpage>–<lpage>1209</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.10.011</pub-id><pub-id pub-id-type="pmid">16343789</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braniste</surname><given-names>V.</given-names></name><name><surname>Al-Asmakh</surname><given-names>M.</given-names></name><name><surname>Kowal</surname><given-names>C.</given-names></name><name><surname>Anuar</surname><given-names>F.</given-names></name><name><surname>Abbaspour</surname><given-names>A.</given-names></name><name><surname>Tóth</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The gut microbiota influences blood-brain barrier permeability in mice</article-title>. <source/>Sci. Transl. Med.
<volume>6</volume>:<fpage>263ra158</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3009759</pub-id><pub-id pub-id-type="pmid">25411471</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branton</surname><given-names>W. G.</given-names></name><name><surname>Ellestad</surname><given-names>K. K.</given-names></name><name><surname>Maingat</surname><given-names>F.</given-names></name><name><surname>Wheatley</surname><given-names>B. M.</given-names></name><name><surname>Rud</surname><given-names>E.</given-names></name><name><surname>Warren</surname><given-names>R. L.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Brain microbial populations in HIV/AIDS: α-proteobacteria predominate independent of host immune status</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e54673</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0054673</pub-id><pub-id pub-id-type="pmid">23355888</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brettschneider</surname><given-names>J.</given-names></name><name><surname>Del Tredici</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>V. M. Y.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name></person-group> (<year>2015</year>). <article-title>Spreading of pathology in neurodegenerative diseases: a focus on human studies</article-title>. <source/>Nat. Rev. Neurosci.
<volume>16</volume>, <fpage>109</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3887</pub-id><pub-id pub-id-type="pmid">25588378</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brizzi</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Neurologic manifestation of Chikungunya virus</article-title>. <source/>Curr. Infect. Dis. Rep.
<volume>19</volume>:<fpage>6</fpage>. <pub-id pub-id-type="doi">10.1007/s11908-017-0561-1</pub-id><pub-id pub-id-type="pmid">28233188</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broderick</surname><given-names>L.</given-names></name><name><surname>Gandhi</surname><given-names>C.</given-names></name><name><surname>Mueller</surname><given-names>J. L.</given-names></name><name><surname>Putnam</surname><given-names>C. D.</given-names></name><name><surname>Shayan</surname><given-names>K.</given-names></name><name><surname>Giclas</surname><given-names>P. C.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis</article-title>. <source/>J. Clin. Immunol.
<volume>33</volume>, <fpage>162</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1007/s10875-012-9767-z</pub-id><pub-id pub-id-type="pmid">22926405</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bu</surname><given-names>X. L.</given-names></name><name><surname>Yao</surname><given-names>X. Q.</given-names></name><name><surname>Jiao</surname><given-names>S. S.</given-names></name><name><surname>Zeng</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>Y. H.</given-names></name><name><surname>Xiang</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>A study on the association between infectious burden and Alzheimer's disease</article-title>. <source/>Eur. J. Neurol.
<volume>22</volume>, <fpage>1519</fpage>–<lpage>1525</lpage>. <pub-id pub-id-type="doi">10.1111/ene.12477</pub-id><pub-id pub-id-type="pmid">24910016</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucciantini</surname><given-names>M.</given-names></name><name><surname>Giannoni</surname><given-names>E.</given-names></name><name><surname>Chiti</surname><given-names>F.</given-names></name><name><surname>Baroni</surname><given-names>F.</given-names></name><name><surname>Formigli</surname><given-names>L.</given-names></name><name><surname>Zurdo</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases</article-title>. <source/>Nature
<volume>416</volume>, <fpage>507</fpage>–<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1038/416507a</pub-id><pub-id pub-id-type="pmid">11932737</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budday</surname><given-names>S.</given-names></name><name><surname>Steinmann</surname><given-names>P.</given-names></name><name><surname>Kuhl</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Physical biology of human brain development</article-title>. <source/>Front. Cell. Neurosci.
<volume>9</volume>:<fpage>257</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00257</pub-id><pub-id pub-id-type="pmid">26217183</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buehler</surname><given-names>M. R.</given-names></name></person-group> (<year>2011</year>). <article-title>A proposed mechanism for autism: an aberrant neuroimmune response manifested as a psychiatric disorder</article-title>. <source/>Med. Hypotheses
<volume>76</volume>, <fpage>863</fpage>–<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2011.02.038</pub-id><pub-id pub-id-type="pmid">21421290</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgdorfer</surname><given-names>W.</given-names></name><name><surname>Barbour</surname><given-names>A. G.</given-names></name><name><surname>Hayes</surname><given-names>S. F.</given-names></name><name><surname>Benach</surname><given-names>J. L.</given-names></name><name><surname>Grunwaldt</surname><given-names>E.</given-names></name><name><surname>Davis</surname><given-names>J. P.</given-names></name></person-group> (<year>1982</year>). <article-title>Lyme disease-a tick-borne spirochetosis?</article-title>
<source/>Science
<volume>216</volume>, <fpage>1317</fpage>–<lpage>1319</lpage>. <pub-id pub-id-type="doi">10.1126/science.7043737</pub-id><pub-id pub-id-type="pmid">7043737</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervantes</surname><given-names>J. L.</given-names></name></person-group> (<year>2017</year>). <article-title>MyD88 in <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source/>Med. Microbiol. Immunol.
<volume>206</volume>, <fpage>187</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1007/s00430-017-0495-0</pub-id><pub-id pub-id-type="pmid">28220253</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>T. J.</given-names></name><name><surname>Diamond</surname><given-names>M. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Pathogenesis of flavivirus encephalitis</article-title>. <source/>Adv. Virus Res.
<volume>60</volume>, <fpage>273</fpage>–<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1016/S0065-3527(03)60008-4</pub-id><pub-id pub-id-type="pmid">14689697</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charo</surname><given-names>I. F.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name></person-group> (<year>2006</year>). <article-title>The many roles of chemokines and chemokine receptors in inflammation</article-title>. <source/>N. Engl. J. Med.
<volume>354</volume>, <fpage>610</fpage>–<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra052723</pub-id><pub-id pub-id-type="pmid">16467548</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Regehr</surname><given-names>W. G.</given-names></name></person-group> (<year>2000</year>). <article-title>Developmental remodeling of the retinogeniculate synapse</article-title>. <source/>Neuron
<volume>28</volume>, <fpage>955</fpage>–<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)00166-5</pub-id><pub-id pub-id-type="pmid">11163279</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Jalabi</surname><given-names>W.</given-names></name><name><surname>Shpargel</surname><given-names>K. B.</given-names></name><name><surname>Farabaugh</surname><given-names>K. T.</given-names></name><name><surname>Dutta</surname><given-names>R.</given-names></name><name><surname>Yin</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>11706</fpage>–<lpage>11715</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0730-12.2012</pub-id><pub-id pub-id-type="pmid">22915113</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ching</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Belevych</surname><given-names>N.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Lai</surname><given-names>W.</given-names></name><name><surname>Pu</surname><given-names>X. A.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>10476</fpage>–<lpage>10486</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3357-07.2007</pub-id><pub-id pub-id-type="pmid">17898219</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>I. M.</given-names></name><name><surname>von Hehn</surname><given-names>C. A.</given-names></name><name><surname>Woolf</surname><given-names>C. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology</article-title>. <source/>Nat. Neurosci.
<volume>15</volume>, <fpage>1063</fpage>–<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3144</pub-id><pub-id pub-id-type="pmid">22837035</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combes</surname><given-names>V.</given-names></name><name><surname>Guillemin</surname><given-names>G. J.</given-names></name><name><surname>Chan-Ling</surname><given-names>T.</given-names></name><name><surname>Hunt</surname><given-names>N. H.</given-names></name><name><surname>Grau</surname><given-names>G. E.</given-names></name></person-group> (<year>2012</year>). <article-title>The crossroads of neuroinflammation in infectious diseases: endothelial cells and astrocytes</article-title>. <source/>Trends Parasitol.
<volume>28</volume>, <fpage>311</fpage>–<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2012.05.008</pub-id><pub-id pub-id-type="pmid">22727810</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czirr</surname><given-names>E.</given-names></name><name><surname>Wyss-Coray</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>The immunology of neurodegeneration</article-title>. <source/>J. Clin. Invest.
<volume>122</volume>, <fpage>1156</fpage>–<lpage>1163</lpage>. <pub-id pub-id-type="doi">10.1172/JCI58656</pub-id><pub-id pub-id-type="pmid">22466657</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahiya</surname><given-names>S.</given-names></name><name><surname>Irish</surname><given-names>B. P.</given-names></name><name><surname>Nonnemacher</surname><given-names>M. R.</given-names></name><name><surname>Wigdahl</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Genetic variation and HIV-associated neurologic disease</article-title>. <source/>Adv. Virus Res.
<volume>87</volume>, <fpage>183</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-407698-3.00006-5</pub-id><pub-id pub-id-type="pmid">23809924</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>M.</given-names></name><name><surname>Freeman</surname><given-names>B.</given-names></name><name><surname>Bruno</surname><given-names>F. P.</given-names></name><name><surname>Shikani</surname><given-names>H. J.</given-names></name><name><surname>Tanowitz</surname><given-names>H. B.</given-names></name><name><surname>Weiss</surname><given-names>L. M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative</article-title>. <source/>Life Sci.
<volume>91</volume>, <fpage>687</fpage>–<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2012.07.006</pub-id><pub-id pub-id-type="pmid">22820174</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daneman</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Agalliu</surname><given-names>D.</given-names></name><name><surname>Cahoy</surname><given-names>J. D.</given-names></name><name><surname>Kaushal</surname><given-names>A.</given-names></name><name><surname>Barres</surname><given-names>B. A.</given-names></name></person-group> (<year>2010a</year>). <article-title>The mouse blood-brain barrier transcriptome: A new resource for understanding the development and function of brain endothelial cells</article-title>. <source/>PLoS ONE
<volume>5</volume>:<fpage>e13741</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0013741</pub-id><pub-id pub-id-type="pmid">21060791</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daneman</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Kebede</surname><given-names>A. A.</given-names></name><name><surname>Barres</surname><given-names>B. A.</given-names></name></person-group> (<year>2010b</year>). <article-title>Pericytes are required for blood-brain barrier integrity during embryogenesis</article-title>. <source/>Nature
<volume>468</volume>, <fpage>562</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1038/nature09513</pub-id><pub-id pub-id-type="pmid">20944625</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname><given-names>B. P.</given-names></name><name><surname>Holman</surname><given-names>D. W.</given-names></name><name><surname>Cruz-Orengo</surname><given-names>L.</given-names></name><name><surname>Jujjavarapu</surname><given-names>H.</given-names></name><name><surname>Durrant</surname><given-names>D. M.</given-names></name><name><surname>Klein</surname><given-names>R. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals</article-title>. <source/>MBio
<volume>5</volume>:<fpage>e01476</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.01476-14</pub-id><pub-id pub-id-type="pmid">25161189</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dantzer</surname><given-names>R.</given-names></name><name><surname>O'Connor</surname><given-names>J. C.</given-names></name><name><surname>Freund</surname><given-names>G. G.</given-names></name><name><surname>Johnson</surname><given-names>R. W.</given-names></name><name><surname>Kelley</surname><given-names>K. W.</given-names></name></person-group> (<year>2008</year>). <article-title>From inflammation to sickness and depression: when the immune system subjugates the brain</article-title>. <source/>Nat. Rev. Neurosci.
<volume>9</volume>, <fpage>46</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2297</pub-id><pub-id pub-id-type="pmid">18073775</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davalos</surname><given-names>D.</given-names></name><name><surname>Grutzendler</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Kim</surname><given-names>J. V.</given-names></name><name><surname>Zuo</surname><given-names>Y.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>ATP mediates rapid microglial response to local brain injury <italic>in vivo</italic></article-title>. <source/>Nat. Neurosci.
<volume>8</volume>, <fpage>752</fpage>–<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1038/nn1472</pub-id><pub-id pub-id-type="pmid">15895084</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davi</surname><given-names>G.</given-names></name><name><surname>Giammarresi</surname><given-names>C.</given-names></name><name><surname>Vigneri</surname><given-names>S.</given-names></name><name><surname>Ganci</surname><given-names>A.</given-names></name><name><surname>Ferri</surname><given-names>C.</given-names></name><name><surname>Di Francesco</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>Demonstration of <italic>Rickettsia conorii</italic>-induced coagulative and platelet activation <italic>in vivo</italic> in patients with mediterranean spotted fever</article-title>. <source/>Thromb. Haemost.
<volume>74</volume>, <fpage>631</fpage>–<lpage>634</lpage>. <pub-id pub-id-type="pmid">8584998</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>S.</given-names></name><name><surname>Kroner</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Repertoire of microglial and macrophage responses after spinal cord injury</article-title>. <source/>Nat. Rev. Neurosci.
<volume>12</volume>, <fpage>388</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3053</pub-id><pub-id pub-id-type="pmid">21673720</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Chiara</surname><given-names>G.</given-names></name><name><surname>Marcocci</surname><given-names>M. E.</given-names></name><name><surname>Sgarbanti</surname><given-names>R.</given-names></name><name><surname>Civitelli</surname><given-names>L.</given-names></name><name><surname>Ripoli</surname><given-names>C.</given-names></name><name><surname>Piacentini</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Infectious agents and neurodegeneration</article-title>. <source/>Mol. Neurobiol.
<volume>46</volume>, <fpage>614</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-012-8320-7</pub-id><pub-id pub-id-type="pmid">22899188</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Rio</surname><given-names>T.</given-names></name><name><surname>Feller</surname><given-names>M. B.</given-names></name></person-group> (<year>2006</year>). <article-title>Early retinal activity and visual circuit development</article-title>. <source/>Neuron
<volume>52</volume>, <fpage>221</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.10.001</pub-id><pub-id pub-id-type="pmid">17046683</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz Heijtz</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Fetal, neonatal, and infant microbiome: Perturbations and subsequent effects on brain development and behavior</article-title>. <source/>Semin. Fetal Neonatal Med.
<volume>21</volume>, <fpage>410</fpage>–<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1016/j.siny.2016.04.012</pub-id><pub-id pub-id-type="pmid">27255860</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinan</surname><given-names>T. G.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name></person-group> (<year>2015</year>). <article-title>The impact of gut microbiota on brain and behaviour: implications for psychiatry</article-title>. <source/>Curr. Opin. Clin. Nutr. Metab. Care
<volume>18</volume>, <fpage>552</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1097/MCO.0000000000000221</pub-id><pub-id pub-id-type="pmid">26372511</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiSabato</surname><given-names>D. J.</given-names></name><name><surname>Quan</surname><given-names>N.</given-names></name><name><surname>Godbout</surname><given-names>J. P.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuroinflammation: the devil is in the details</article-title>. <source/>J. Neurochem.
<volume>139</volume>(<issue>Suppl. 2</issue>), <fpage>136</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13607</pub-id><pub-id pub-id-type="pmid">26990767</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>A. J.</given-names></name><name><surname>Swiergiel</surname><given-names>A. H.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Quan</surname><given-names>N.</given-names></name></person-group> (<year>2006</year>). <article-title>Reduced ingestion of sweetened milk induced by interleukin-1 and lipopolysaccharide is associated with induction of Cyclooxygenase-2 in brain endothelia</article-title>. <source/>Neuroimmunomodulation
<volume>13</volume>, <fpage>96</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1159/000096291</pub-id><pub-id pub-id-type="pmid">17047394</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Aidy</surname><given-names>S.</given-names></name><name><surname>Dinan</surname><given-names>T.</given-names></name><name><surname>Cryan</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Immune modulation of the brain-gut-microbe axis</article-title>. <source/>Front. Microbiol.
<volume>5</volume>:<fpage>146</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2014.00146</pub-id><pub-id pub-id-type="pmid">24778631</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elinav</surname><given-names>E.</given-names></name><name><surname>Strowig</surname><given-names>T.</given-names></name><name><surname>Henao-Mejia</surname><given-names>J.</given-names></name><name><surname>Flavell</surname><given-names>R. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Regulation of the antimicrobial response by NLR proteins</article-title>. <source/>Immunity
<volume>34</volume>, <fpage>665</fpage>–<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2011.05.007</pub-id><pub-id pub-id-type="pmid">21616436</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelhardt</surname><given-names>B.</given-names></name><name><surname>Liebner</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Novel insights into the development and maintenance of the blood-brain barrier</article-title>. <source/>Cell Tissue Res.
<volume>355</volume>, <fpage>687</fpage>–<lpage>699</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-014-1811-2</pub-id><pub-id pub-id-type="pmid">24590145</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farzi</surname><given-names>A.</given-names></name><name><surname>Reichmann</surname><given-names>F.</given-names></name><name><surname>Meinitzer</surname><given-names>A.</given-names></name><name><surname>Mayerhofer</surname><given-names>R.</given-names></name><name><surname>Jain</surname><given-names>P.</given-names></name><name><surname>Hassan</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers</article-title>. <source/>Brain Behav. Immun.
<volume>44</volume>, <fpage>106</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2014.08.011</pub-id><pub-id pub-id-type="pmid">25218901</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>C. C.</given-names></name><name><surname>Depino</surname><given-names>A. M.</given-names></name><name><surname>Prada</surname><given-names>F.</given-names></name><name><surname>Muraro</surname><given-names>N.</given-names></name><name><surname>Campbell</surname><given-names>S.</given-names></name><name><surname>Podhajcer</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain</article-title>. <source/>Am. J. Pathol.
<volume>165</volume>, <fpage>1827</fpage>–<lpage>1837</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)63438-4</pub-id><pub-id pub-id-type="pmid">15509551</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferwerda</surname><given-names>B.</given-names></name><name><surname>Valls Serón</surname><given-names>M.</given-names></name><name><surname>Jongejan</surname><given-names>A.</given-names></name><name><surname>Zwinderman</surname><given-names>A. H.</given-names></name><name><surname>Geldhoff</surname><given-names>M.</given-names></name><name><surname>van der Ende</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Variation of 46 innate immune genes evaluated for their contribution in pneumococcal meningitis susceptibility and outcome</article-title>. <source/>EBioMed.
<volume>10</volume>, <fpage>77</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2016.07.011</pub-id><pub-id pub-id-type="pmid">27432718</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiorentino</surname><given-names>M.</given-names></name><name><surname>Sapone</surname><given-names>A.</given-names></name><name><surname>Senger</surname><given-names>S.</given-names></name><name><surname>Camhi</surname><given-names>S. S.</given-names></name><name><surname>Kadzielski</surname><given-names>S. M.</given-names></name><name><surname>Buie</surname><given-names>T. M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders</article-title>. <source/>Mol. Autism
<volume>7</volume>, <fpage>49</fpage>. <pub-id pub-id-type="doi">10.1186/s13229-016-0110-z</pub-id><pub-id pub-id-type="pmid">27957319</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floret</surname><given-names>D.</given-names></name><name><surname>Stamm</surname><given-names>D.</given-names></name><name><surname>Ponard</surname><given-names>D.</given-names></name></person-group> (<year>1991</year>). <article-title>Increased susceptibility to infection in children with congenital deficiency of factor I</article-title>. <source/>Pediatr. Infect. Dis. J.
<volume>10</volume>, <fpage>615</fpage>–<lpage>618</lpage>. <pub-id pub-id-type="doi">10.1097/00006454-199108000-00011</pub-id><pub-id pub-id-type="pmid">1832491</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francisco</surname><given-names>N. M.</given-names></name><name><surname>Hsu</surname><given-names>N. J.</given-names></name><name><surname>Keeton</surname><given-names>R.</given-names></name><name><surname>Randall</surname><given-names>P.</given-names></name><name><surname>Sebesho</surname><given-names>B.</given-names></name><name><surname>Allie</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>TNF-dependent regulation and activation of innate immune cells are essential for host protection against cerebral tuberculosis</article-title>. <source/>J. Neuroinflam.
<volume>12</volume>, <fpage>125</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-015-0345-1</pub-id><pub-id pub-id-type="pmid">26112704</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>B. D.</given-names></name><name><surname>Machado</surname><given-names>F. S.</given-names></name><name><surname>Tanowitz</surname><given-names>H. B.</given-names></name><name><surname>Desruisseaux</surname><given-names>M. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Endothelin-1 and its role in the pathogenesis of infectious diseases</article-title>. <source/>Life Sci.
<volume>118</volume>, <fpage>110</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2014.04.021</pub-id><pub-id pub-id-type="pmid">24780317</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furr</surname><given-names>S.</given-names></name><name><surname>Marriott</surname><given-names>I.</given-names></name></person-group> (<year>2012</year>). <article-title>Viral CNS infections: role of glial pattern recognition receptors in neuroinflammation</article-title>. <source/>Front. Microbiol.
<volume>3</volume>:<fpage>201</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2012.00201</pub-id><pub-id pub-id-type="pmid">22723794</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geldhoff</surname><given-names>M.</given-names></name><name><surname>Mook-Kanamori</surname><given-names>B. B.</given-names></name><name><surname>Brouwer</surname><given-names>M. C.</given-names></name><name><surname>Valls Seron</surname><given-names>M.</given-names></name><name><surname>Baas</surname><given-names>F.</given-names></name><name><surname>van der Ende</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Genetic variation in inflammasome genes is associated with outcome in bacterial meningitis</article-title>. <source/>Immunogenetics
<volume>65</volume>, <fpage>9</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1007/s00251-012-0653-x</pub-id><pub-id pub-id-type="pmid">23053059</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerardin</surname><given-names>P.</given-names></name><name><surname>Couderc</surname><given-names>T.</given-names></name><name><surname>Bintner</surname><given-names>M.</given-names></name><name><surname>Tournebize</surname><given-names>P.</given-names></name><name><surname>Renouil</surname><given-names>M.</given-names></name><name><surname>Lemant</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Chikungunya virus-associated encephalitis: a cohort study on LA Reunion island, 2005-2009</article-title>. <source/>Neurology
<volume>86</volume>, <fpage>94</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000002234</pub-id><pub-id pub-id-type="pmid">26609145</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F.</given-names></name><name><surname>Greter</surname><given-names>M.</given-names></name><name><surname>Leboeuf</surname><given-names>M.</given-names></name><name><surname>Nandi</surname><given-names>S.</given-names></name><name><surname>See</surname><given-names>P.</given-names></name><name><surname>Gokhan</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Fate mapping analysis reveals that adult microglia derive from primitive macrophages</article-title>. <source/>Science
<volume>330</volume>, <fpage>841</fpage>–<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1126/science.1194637</pub-id><pub-id pub-id-type="pmid">20966214</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldmann</surname><given-names>J.</given-names></name><name><surname>Kwidzinski</surname><given-names>E.</given-names></name><name><surname>Brandt</surname><given-names>C.</given-names></name><name><surname>Mahlo</surname><given-names>J.</given-names></name><name><surname>Richter</surname><given-names>D.</given-names></name><name><surname>Bechmann</surname><given-names>I.</given-names></name></person-group> (<year>2006</year>). <article-title>T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa</article-title>. <source/>J. Leukoc. Biol.
<volume>80</volume>, <fpage>797</fpage>–<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0306176</pub-id><pub-id pub-id-type="pmid">16885505</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grayston</surname><given-names>J. T.</given-names></name><name><surname>Campbell</surname><given-names>L. A.</given-names></name><name><surname>Kuo</surname><given-names>C.-C.</given-names></name><name><surname>Mordhorst</surname><given-names>C. H.</given-names></name><name><surname>Saikku</surname><given-names>P.</given-names></name><name><surname>Thorn</surname><given-names>D. H.</given-names></name><etal></etal></person-group>. (<year>1990</year>). <article-title>A new respiratory tract pathogen: <italic>Chlamydia pneumoniae</italic> strain TWAR</article-title>. <source/>J. Infect. Dis.
<volume>161</volume>, <fpage>618</fpage>–<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/161.4.618</pub-id><pub-id pub-id-type="pmid">2181028</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>J. A.</given-names></name><name><surname>Friedland</surname><given-names>J. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Astrocyte–leucocyte interactions and the mechanisms regulating matrix degradation in CNS tuberculosis</article-title>. <source/>Biochem. Soc. Trans.
<volume>35</volume>:<fpage>686</fpage>. <pub-id pub-id-type="doi">10.1042/BST0350686</pub-id><pub-id pub-id-type="pmid">17635122</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruber-Schoffnegger</surname><given-names>D.</given-names></name><name><surname>Drdla-Schutting</surname><given-names>R.</given-names></name><name><surname>Honigsperger</surname><given-names>C.</given-names></name><name><surname>Wunderbaldinger</surname><given-names>G.</given-names></name><name><surname>Gassner</surname><given-names>M.</given-names></name><name><surname>Sandkuhler</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Induction of thermal hyperalgesia and synaptic long-term potentiation in the spinal cord lamina i by TNF-α and IL-1β is mediated by glial cells</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>6540</fpage>–<lpage>6551</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5087-12.2013</pub-id><pub-id pub-id-type="pmid">23575851</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guabiraba</surname><given-names>R.</given-names></name><name><surname>Ryffel</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Dengue virus infection: Current concepts in immune mechanisms and lessons from murine models</article-title>. <source/>Immunology
<volume>141</volume>, <fpage>143</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12188</pub-id><pub-id pub-id-type="pmid">24182427</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerreiro</surname><given-names>R.</given-names></name><name><surname>Wojtas</surname><given-names>A.</given-names></name><name><surname>Bras</surname><given-names>J.</given-names></name><name><surname>Carrasquillo</surname><given-names>M.</given-names></name><name><surname>Rogaeva</surname><given-names>E.</given-names></name><name><surname>Majounie</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>TREM2 variants in Alzheimer's disease</article-title>. <source/>N. Engl. J. Med.
<volume>368</volume>, <fpage>117</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1211851</pub-id><pub-id pub-id-type="pmid">23150934</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haerynck</surname><given-names>F.</given-names></name><name><surname>Stordeur</surname><given-names>P.</given-names></name><name><surname>Vandewalle</surname><given-names>J.</given-names></name><name><surname>Van Coster</surname><given-names>R.</given-names></name><name><surname>Bordon</surname><given-names>V.</given-names></name><name><surname>De Baets</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Complete factor I deficiency due to dysfunctional factor I with recurrent aseptic meningo-encephalitis</article-title>. <source/>J. Clin. Immunol.
<volume>33</volume>, <fpage>1293</fpage>–<lpage>1301</lpage>. <pub-id pub-id-type="doi">10.1007/s10875-013-9944-8</pub-id><pub-id pub-id-type="pmid">24142231</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanke</surname><given-names>M. L.</given-names></name><name><surname>Kielian</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential</article-title>. <source/>Clin. Sci.
<volume>121</volume>, <fpage>367</fpage>–<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1042/CS20110164</pub-id><pub-id pub-id-type="pmid">21745188</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>M. K.</given-names></name><name><surname>O'Connor</surname><given-names>K. A.</given-names></name><name><surname>Goehler</surname><given-names>L. E.</given-names></name><name><surname>Watkins</surname><given-names>L. R.</given-names></name><name><surname>Maier</surname><given-names>S. F.</given-names></name></person-group> (<year>2001</year>). <article-title>The contribution of the vagus nerve in interleukin-1β-induced fever is dependent on dose</article-title>. <source/>Am. J. Physiol. Regul. Integr. Comp. Physiol.
<volume>280</volume>, <fpage>R929</fpage>–<lpage>R934</lpage>. <pub-id pub-id-type="pmid">11247812</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>S. A.</given-names></name><name><surname>Harris</surname><given-names>E. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Herpes simplex virus type 1 and other pathogens are key causative factors in sporadic Alzheimer's disease</article-title>. <source/>J. Alzheimers Dis.
<volume>48</volume>, <fpage>319</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-142853</pub-id><pub-id pub-id-type="pmid">26401998</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>C. J.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Wynne</surname><given-names>A. M.</given-names></name><name><surname>Godbout</surname><given-names>J. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines</article-title>. <source/>Brain Behav. Immun.
<volume>23</volume>, <fpage>309</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2008.09.002</pub-id><pub-id pub-id-type="pmid">18814846</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>J. M.</given-names></name><name><surname>Clement</surname><given-names>C.</given-names></name><name><surname>Pogue</surname><given-names>A. I.</given-names></name><name><surname>Bhattacharjee</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Lukiw</surname><given-names>W. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Pathogenic microbes, the microbiome, and Alzheimer's disease (ad)</article-title>. <source/>Front. Aging Neurosci.
<volume>6</volume>:<fpage>127</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2014.00127</pub-id><pub-id pub-id-type="pmid">24982633</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>Y.-H.</given-names></name><name><surname>Lin</surname><given-names>Y.-T.</given-names></name><name><surname>Wu</surname><given-names>C.-W. J.</given-names></name><name><surname>Chao</surname><given-names>Y.-M.</given-names></name><name><surname>Chang</surname><given-names>A. Y. W.</given-names></name><name><surname>Chan</surname><given-names>J. Y. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus</article-title>. <source/>J. Biomed. Sci.
<volume>22</volume>, <fpage>46</fpage>. <pub-id pub-id-type="doi">10.1186/s12929-015-0157-8</pub-id><pub-id pub-id-type="pmid">26100815</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imeri</surname><given-names>L.</given-names></name><name><surname>Opp</surname><given-names>M. R.</given-names></name></person-group> (<year>2009</year>). <article-title>How (and why) the immune system makes us sleep</article-title>. <source/>Nat. Rev. Neurosci.
<volume>10</volume>, <fpage>199</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2576</pub-id><pub-id pub-id-type="pmid">19209176</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itzhaki</surname><given-names>R. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Herpes simplex virus type 1 and Alzheimer's disease: Increasing evidence for a major role of the virus</article-title>. <source/>Front. Aging Neurosci.
<volume>6</volume>:<fpage>202</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2014.00202</pub-id><pub-id pub-id-type="pmid">25157230</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Endothelin-1: A potential pathological factor in Parkinson's disease?-from endoplasmic reticulum stress to beyond</article-title>. <source/>J. Neurol. Sci.
<volume>344</volume>, <fpage>236</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2014.06.038</pub-id><pub-id pub-id-type="pmid">24998514</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S. K.</given-names></name><name><surname>Paul-Satyaseela</surname><given-names>M.</given-names></name><name><surname>Lamichhane</surname><given-names>G.</given-names></name><name><surname>Kim</surname><given-names>K. S.</given-names></name><name><surname>Bishai</surname><given-names>W. R.</given-names></name></person-group> (<year>2006</year>). <article-title><italic>Mycobacterium tuberculosis</italic> invasion and traversal across an <italic>in vitro</italic> human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis</article-title>. <source/>J. Infect. Dis.
<volume>193</volume>, <fpage>1287</fpage>–<lpage>1295</lpage>. <pub-id pub-id-type="doi">10.1086/502631</pub-id><pub-id pub-id-type="pmid">16586367</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>J. T.</given-names></name><name><surname>Zhu</surname><given-names>X. C.</given-names></name><name><surname>Tan</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>TREM2 in Alzheimer's disease</article-title>. <source/>Mol. Neurobiol.
<volume>48</volume>, <fpage>180</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-013-8424-8</pub-id><pub-id pub-id-type="pmid">23407992</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonsson</surname><given-names>T.</given-names></name><name><surname>Stefansson</surname><given-names>H.</given-names></name><name><surname>Steinberg</surname><given-names>S.</given-names></name><name><surname>Jonsdottir</surname><given-names>I.</given-names></name><name><surname>Jonsson</surname><given-names>P. V.</given-names></name><name><surname>Snaedal</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Variant of TREM2 associated with the risk of Alzheimer's disease</article-title>. <source/>N. Engl. J. Med.
<volume>368</volume>, <fpage>107</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1211103</pub-id><pub-id pub-id-type="pmid">23150908</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaisho</surname><given-names>T.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Pleiotropic function of toll-like receptors</article-title>. <source/>Microbes Infect.
<volume>6</volume>, <fpage>1388</fpage>–<lpage>1394</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2004.08.019</pub-id><pub-id pub-id-type="pmid">15596125</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kariko</surname><given-names>K.</given-names></name><name><surname>Ni</surname><given-names>H.</given-names></name><name><surname>Capodici</surname><given-names>J.</given-names></name><name><surname>Lamphier</surname><given-names>M.</given-names></name><name><surname>Weissman</surname><given-names>D.</given-names></name></person-group> (<year>2004</year>). <article-title>mRNA is an endogenous ligand for toll-like receptor 3</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>, <fpage>12542</fpage>–<lpage>12550</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M310175200</pub-id><pub-id pub-id-type="pmid">14729660</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khachaturian</surname><given-names>Z. S.</given-names></name></person-group> (<year>1985</year>). <article-title>Diagnosis of Alzheimer's disease</article-title>. <source/>Arch. Neurol.
<volume>42</volume>, <fpage>1097</fpage>–<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.1985.04060100083029</pub-id><pub-id pub-id-type="pmid">2864910</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirschning</surname><given-names>C. J.</given-names></name><name><surname>Schumann</surname><given-names>R. R.</given-names></name></person-group> (<year>2002</year>). <article-title>TLR2: Cellular sensor for microbial and endogenous molecular patterns</article-title>. <source/>Curr. Top. Microbiol. Immunol.
<volume>270</volume>, <fpage>121</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-642-59430-4_8</pub-id><pub-id pub-id-type="pmid">12467248</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohan</surname><given-names>D. E.</given-names></name><name><surname>Rossi</surname><given-names>N. F.</given-names></name><name><surname>Inscho</surname><given-names>E. W.</given-names></name><name><surname>Pollock</surname><given-names>D. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Regulation of blood pressure and salt homeostasis by endothelin</article-title>. <source/>Physiol. Rev.
<volume>91</volume>, <fpage>1</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00060.2009</pub-id><pub-id pub-id-type="pmid">21248162</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname><given-names>Y.</given-names></name><name><surname>Lackay</surname><given-names>S. N.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Fu</surname><given-names>Z. F.</given-names></name></person-group> (<year>2009</year>). <article-title>Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after Rabies virus infection</article-title>. <source/>Virus Res.
<volume>144</volume>, <fpage>18</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2009.03.014</pub-id><pub-id pub-id-type="pmid">19720239</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laflamme</surname><given-names>N.</given-names></name><name><surname>Lacroix</surname><given-names>S.</given-names></name><name><surname>Rivest</surname><given-names>S.</given-names></name></person-group> (<year>1999</year>). <article-title>An essential role of interleukin-1β in mediating NF-κB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>10923</fpage>–<lpage>10930</lpage>.<pub-id pub-id-type="pmid">10594073</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>E.</given-names></name><name><surname>Lobigs</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray valley encephalitis virus</article-title>. <source/>J. Virol.
<volume>76</volume>, <fpage>4901</fpage>–<lpage>4911</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.76.10.4901-4911.2002</pub-id><pub-id pub-id-type="pmid">11967307</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Ling</surname><given-names>C.</given-names></name><name><surname>Kosmalski</surname><given-names>M. M.</given-names></name><name><surname>Hulseberg</surname><given-names>P.</given-names></name><name><surname>Schreiber</surname><given-names>H. A.</given-names></name><name><surname>Sandor</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Intracerebral <italic>Mycobacterium bovis</italic> bacilli calmette-guerin infection-induced immune responses in the CNS</article-title>. <source/>J. Neuroimmunol.
<volume>213</volume>, <fpage>112</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2009.05.008</pub-id><pub-id pub-id-type="pmid">19535154</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leitao</surname><given-names>M. F.</given-names></name><name><surname>Vilela</surname><given-names>M. M.</given-names></name><name><surname>Rutz</surname><given-names>R.</given-names></name><name><surname>Grumach</surname><given-names>A. S.</given-names></name><name><surname>Condino-Neto</surname><given-names>A.</given-names></name><name><surname>Kirschfink</surname><given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>Complement factor I deficiency in a family with recurrent infections</article-title>. <source/>Immunopharmacology
<volume>38</volume>, <fpage>207</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1016/S0162-3109(97)00080-5</pub-id><pub-id pub-id-type="pmid">9476132</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>R. E.</given-names></name><name><surname>Peterson</surname><given-names>D. A.</given-names></name><name><surname>Gordon</surname><given-names>J. I.</given-names></name></person-group> (<year>2006</year>). <article-title>Ecological and evolutionary forces shaping microbial diversity in the human intestine</article-title>. <source/>Cell
<volume>124</volume>, <fpage>837</fpage>–<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.02.017</pub-id><pub-id pub-id-type="pmid">16497592</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Ye</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Persidsky</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages</article-title>. <source/>Blood
<volume>121</volume>, <fpage>2934</fpage>–<lpage>2942</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2012-08-450353</pub-id><pub-id pub-id-type="pmid">23401273</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S. L.</given-names></name><name><surname>Rodriguez-Ortiz</surname><given-names>C. J.</given-names></name><name><surname>Kitazawa</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Infection, systemic inflammation, and Alzheimer's disease</article-title>. <source/>Microbes Infect.
<volume>17</volume>, <fpage>549</fpage>–<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2015.04.004</pub-id><pub-id pub-id-type="pmid">25912134</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindenbach</surname><given-names>B. D.</given-names></name><name><surname>Rice</surname><given-names>C. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Molecular biology of flaviviruses</article-title>. <source/>Adv. Virus Res.
<volume>59</volume>, <fpage>23</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/S0065-3527(03)59002-9</pub-id><pub-id pub-id-type="pmid">14696326</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippmann</surname><given-names>E. S.</given-names></name><name><surname>Al-Ahmad</surname><given-names>A.</given-names></name><name><surname>Palecek</surname><given-names>S. P.</given-names></name><name><surname>Shusta</surname><given-names>E. V.</given-names></name></person-group> (<year>2013</year>). <article-title>Modeling the blood-brain barrier using stem cell sources</article-title>. <source/>Fluids Barriers CNS
<volume>10</volume>:<fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/2045-8118-10-2</pub-id><pub-id pub-id-type="pmid">23305164</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippmann</surname><given-names>E. S.</given-names></name><name><surname>Azarin</surname><given-names>S. M.</given-names></name><name><surname>Kay</surname><given-names>J. E.</given-names></name><name><surname>Nessler</surname><given-names>R. A.</given-names></name><name><surname>Wilson</surname><given-names>H. K.</given-names></name><name><surname>Al-Ahmad</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells</article-title>. <source/>Nat. Biotechnol.
<volume>30</volume>, <fpage>783</fpage>–<lpage>791</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2247</pub-id><pub-id pub-id-type="pmid">22729031</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C. C.</given-names></name><name><surname>Kanekiyo</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Bu</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy</article-title>. <source/>Nat. Rev. Neurol.
<volume>9</volume>, <fpage>106</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2012.263</pub-id><pub-id pub-id-type="pmid">23296339</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Nemeth</surname><given-names>D. P.</given-names></name><name><surname>Tarr</surname><given-names>A. J.</given-names></name><name><surname>Belevych</surname><given-names>N.</given-names></name><name><surname>Syed</surname><given-names>Z. W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling</article-title>. <source/>Brain Behav. Immun.
<volume>54</volume>, <fpage>140</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.01.018</pub-id><pub-id pub-id-type="pmid">26812118</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>K. M.</given-names></name><name><surname>Whitmore</surname><given-names>A. C.</given-names></name><name><surname>Ferris</surname><given-names>M. T.</given-names></name><name><surname>Sempowski</surname><given-names>G. D.</given-names></name><name><surname>McGee</surname><given-names>C.</given-names></name><name><surname>Trollinger</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice</article-title>. <source/>J. Virol.
<volume>87</volume>, <fpage>5697</fpage>–<lpage>5706</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01611-12</pub-id><pub-id pub-id-type="pmid">23487448</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louveau</surname><given-names>A.</given-names></name><name><surname>Smirnov</surname><given-names>I.</given-names></name><name><surname>Keyes</surname><given-names>T. J.</given-names></name><name><surname>Eccles</surname><given-names>J. D.</given-names></name><name><surname>Rouhani</surname><given-names>S. J.</given-names></name><name><surname>Peske</surname><given-names>J. D.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Structural and functional features of central nervous system lymphatic vessels</article-title>. <source/>Nature
<volume>523</volume>, <fpage>337</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1038/nature14432</pub-id><pub-id pub-id-type="pmid">26030524</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lum</surname><given-names>F. M.</given-names></name><name><surname>Low</surname><given-names>D. K.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Tan</surname><given-names>J. J.</given-names></name><name><surname>Lee</surname><given-names>B.</given-names></name><name><surname>Chan</surname><given-names>J. K.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Zika virus infects human fetal brain microglia and induces inflammation</article-title>. <source/>Clin. Infect. Dis.
<volume>64</volume>, <fpage>914</fpage>–<lpage>920</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciw878</pub-id><pub-id pub-id-type="pmid">28362944</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundbo</surname><given-names>L. F.</given-names></name><name><surname>Harboe</surname><given-names>Z. B.</given-names></name><name><surname>Clausen</surname><given-names>L. N.</given-names></name><name><surname>Hollegaard</surname><given-names>M. V.</given-names></name><name><surname>Sorensen</surname><given-names>H. T.</given-names></name><name><surname>Hougaard</surname><given-names>D. M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Genetic variation in NFKBIE is associated with increased risk of pneumococcal meningitis in children</article-title>. <source/>EBioMed.
<volume>3</volume>, <fpage>93</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2015.11.048</pub-id><pub-id pub-id-type="pmid">26870821</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundbo</surname><given-names>L. F.</given-names></name><name><surname>Sorensen</surname><given-names>H. T.</given-names></name><name><surname>Clausen</surname><given-names>L. N.</given-names></name><name><surname>Hollegaard</surname><given-names>M. V.</given-names></name><name><surname>Hougaard</surname><given-names>D. M.</given-names></name><name><surname>Konradsen</surname><given-names>H. B.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Mannose-binding lectin gene, MBL2, polymorphisms do not increase susceptibility to invasive meningococcal disease in a population of Danish children</article-title>. <source/>Open Forum Infect. Dis.
<volume>2</volume>:<fpage>ofv127</fpage>
<pub-id pub-id-type="doi">10.1093/ofid/ofv127</pub-id><pub-id pub-id-type="pmid">26464842</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S.</given-names></name><name><surname>Kwon</surname><given-names>H. J.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name></person-group> (<year>2012</year>). <article-title>A functional requirement for astroglia in promoting blood vessel development in the early postnatal brain</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e48001</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0048001</pub-id><pub-id pub-id-type="pmid">23110156</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maheshwari</surname><given-names>P.</given-names></name><name><surname>Eslick</surname><given-names>G. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Bacterial infection and Alzheimer's disease: a meta-analysis</article-title>. <source/>J. Alzheimers Dis.
<volume>43</volume>, <fpage>957</fpage>–<lpage>966</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-140621</pub-id><pub-id pub-id-type="pmid">25182736</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>S. F.</given-names></name><name><surname>Goehler</surname><given-names>L. E.</given-names></name><name><surname>Fleshner</surname><given-names>M.</given-names></name><name><surname>Watkins</surname><given-names>L. R.</given-names></name></person-group> (<year>1998</year>). <article-title>The role of the vagus nerve in cytokine-to-brain communication</article-title>. <source/>Ann. N.Y. Acad. Sci.
<volume>840</volume>, <fpage>289</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1998.tb09569.x</pub-id><pub-id pub-id-type="pmid">9629257</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancuso</surname><given-names>R.</given-names></name><name><surname>Baglio</surname><given-names>F.</given-names></name><name><surname>Agostini</surname><given-names>S.</given-names></name><name><surname>Cabinio</surname><given-names>M.</given-names></name><name><surname>Lagana</surname><given-names>M. M.</given-names></name><name><surname>Hernis</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer's disease and amnestic mild cognitive impairment</article-title>. <source/>Front. Aging Neurosci.
<volume>6</volume>:<fpage>285</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2014.00285</pub-id><pub-id pub-id-type="pmid">25360113</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>E. A.</given-names></name><name><surname>Padua</surname><given-names>D.</given-names></name><name><surname>Tillisch</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Altered brain-gut axis in autism: comorbidity or causative mechanisms?</article-title>
<source/>Bioessays
<volume>36</volume>, <fpage>933</fpage>–<lpage>939</lpage>. <pub-id pub-id-type="doi">10.1002/bies.201400075</pub-id><pub-id pub-id-type="pmid">25145752</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayerhofer</surname><given-names>R.</given-names></name><name><surname>Frohlich</surname><given-names>E. E.</given-names></name><name><surname>Reichmann</surname><given-names>F.</given-names></name><name><surname>Farzi</surname><given-names>A.</given-names></name><name><surname>Kogelnik</surname><given-names>N.</given-names></name><name><surname>Frohlich</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Diverse action of lipoteichoic acid and lipopolysaccharide on neuroinflammation, blood-brain barrier disruption, and anxiety in mice</article-title>. <source/>Brain Behav. Immun.
<volume>60</volume>, <fpage>174</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.10.011</pub-id><pub-id pub-id-type="pmid">27751870</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCusker</surname><given-names>R. H.</given-names></name><name><surname>Kelley</surname><given-names>K. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Immune–neural connections: how the immune system's response to infectious agents influences behavior</article-title>. <source/>J. Exp. Biol.
<volume>216</volume>, <fpage>84</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1242/jeb.073411</pub-id><pub-id pub-id-type="pmid">23225871</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McManus</surname><given-names>R. M.</given-names></name><name><surname>Heneka</surname><given-names>M. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of neuroinflammation in neurodegeneration: new insights</article-title>. <source/>Alzheimers Res. Ther.
<volume>9</volume>, <fpage>14</fpage>. <pub-id pub-id-type="doi">10.1186/s13195-017-0241-2</pub-id><pub-id pub-id-type="pmid">28259169</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McManus</surname><given-names>R. M.</given-names></name><name><surname>Higgins</surname><given-names>S. C.</given-names></name><name><surname>Mills</surname><given-names>K. H. G.</given-names></name><name><surname>Lynch</surname><given-names>M. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice</article-title>. <source/>Neurobiol. Aging
<volume>35</volume>, <fpage>109</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2013.07.025</pub-id><pub-id pub-id-type="pmid">23993702</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Origin and physiological roles of inflammation</article-title>. <source/>Nature
<volume>454</volume>, <fpage>428</fpage>–<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1038/nature07201</pub-id><pub-id pub-id-type="pmid">18650913</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miklossy</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria</article-title>. <source/>J. Neuroinflammation
<volume>8</volume>:<fpage>90</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-8-90</pub-id><pub-id pub-id-type="pmid">21816039</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miklossy</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Historic evidence to support a causal relationship between spirochetal infections and Alzheimer's disease</article-title>. <source/>Front. Aging Neurosci.
<volume>7</volume>:<fpage>46</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2015.00046</pub-id><pub-id pub-id-type="pmid">25932012</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miklossy</surname><given-names>J.</given-names></name><name><surname>Kis</surname><given-names>A.</given-names></name><name><surname>Radenovic</surname><given-names>A.</given-names></name><name><surname>Miller</surname><given-names>L.</given-names></name><name><surname>Forro</surname><given-names>L.</given-names></name><name><surname>Martins</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>β-amyloid deposition and Alzheimer's type changes induced by <italic>Borrelia spirochetes</italic></article-title>. <source/>Neurobiol. Aging
<volume>27</volume>, <fpage>228</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.01.018</pub-id><pub-id pub-id-type="pmid">15894409</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>A. H.</given-names></name><name><surname>Raison</surname><given-names>C. L.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of inflammation in depression: from evolutionary imperative to modern treatment target</article-title>. <source/>Nat. Rev. Immunol.
<volume>16</volume>, <fpage>22</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2015.5</pub-id><pub-id pub-id-type="pmid">26711676</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miner</surname><given-names>J. J.</given-names></name><name><surname>Diamond</surname><given-names>M. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Mechanisms of restriction of viral neuroinvasion at the blood–brain barrier</article-title>. <source/>Curr. Opin. Immunol.
<volume>38</volume>, <fpage>18</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2015.10.008</pub-id><pub-id pub-id-type="pmid">26590675</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minter</surname><given-names>M. R.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Leone</surname><given-names>V.</given-names></name><name><surname>Ringus</surname><given-names>D. L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Oyler-Castrillo</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and Amyloidosis in a murine model of Alzheimer's disease</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>30028</fpage>. <pub-id pub-id-type="doi">10.1038/srep30028</pub-id><pub-id pub-id-type="pmid">27443609</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molteni</surname><given-names>M.</given-names></name><name><surname>Gemma</surname><given-names>S.</given-names></name><name><surname>Rossetti</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of toll-like receptor 4 in infectious and noninfectious inflammation</article-title>. <source/>Mediators Inflamm.
<volume>2016</volume>:<fpage>6978936</fpage>. <pub-id pub-id-type="doi">10.1155/2016/6978936</pub-id><pub-id pub-id-type="pmid">27293318</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moretti</surname><given-names>R.</given-names></name><name><surname>Pansiot</surname><given-names>J.</given-names></name><name><surname>Bettati</surname><given-names>D.</given-names></name><name><surname>Strazielle</surname><given-names>N.</given-names></name><name><surname>Ghersi-Egea</surname><given-names>J. F.</given-names></name><name><surname>Damante</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Blood-brain barrier dysfunction in disorders of the developing brain</article-title>. <source/>Front. Neurosci.
<volume>9</volume>:<fpage>40</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2015.00040</pub-id><pub-id pub-id-type="pmid">25741233</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mundt</surname><given-names>S.</given-names></name><name><surname>Engelhardt</surname><given-names>B.</given-names></name><name><surname>Kirk</surname><given-names>C. J.</given-names></name><name><surname>Groettrup</surname><given-names>M.</given-names></name><name><surname>Basler</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Inhibition and deficiency of the immunoproteasome subunit LMP7 attenuates LCMV-induced meningitis</article-title>. <source/>Eur. J. Immunol.
<volume>46</volume>, <fpage>104</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201545578</pub-id><pub-id pub-id-type="pmid">26464284</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>S. C.</given-names></name><name><surname>Trouw</surname><given-names>L. A.</given-names></name><name><surname>Renault</surname><given-names>N.</given-names></name><name><surname>Miteva</surname><given-names>M. A.</given-names></name><name><surname>Genel</surname><given-names>F.</given-names></name><name><surname>Zelazko</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Genetic, molecular and functional analyses of complement factor I deficiency</article-title>. <source/>Eur. J. Immunol.
<volume>39</volume>, <fpage>310</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200838702</pub-id><pub-id pub-id-type="pmid">19065647</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimmerjahn</surname><given-names>A.</given-names></name><name><surname>Kirchhoff</surname><given-names>F.</given-names></name><name><surname>Helmchen</surname><given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>Resting microglial cells are highly dynamic surveillants of brain parenchyma <italic>in vivo</italic></article-title>. <source/>Science
<volume>308</volume>, <fpage>1314</fpage>–<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1126/science.1110647</pub-id><pub-id pub-id-type="pmid">15831717</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niwa</surname><given-names>K.</given-names></name><name><surname>Carlson</surname><given-names>G. A.</given-names></name><name><surname>Iadecola</surname><given-names>C.</given-names></name></person-group> (<year>2000</year>). <article-title>Exogenous aβ1–40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>20</volume>, <fpage>1659</fpage>–<lpage>1668</lpage>. <pub-id pub-id-type="doi">10.1097/00004647-200012000-00005</pub-id><pub-id pub-id-type="pmid">11129782</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norden</surname><given-names>D. M.</given-names></name><name><surname>Godbout</surname><given-names>J. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Review: microglia of the aged brain: primed to be activated and resistant to regulation</article-title>. <source/>Neuropathol. Appl. Neurobiol.
<volume>39</volume>, <fpage>19</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2990.2012.01306.x</pub-id><pub-id pub-id-type="pmid">23039106</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname><given-names>M. G.</given-names></name><name><surname>O'Kusky</surname><given-names>J. R.</given-names></name></person-group> (<year>1986</year>). <article-title>The growth and development of microvasculature in human cerebral cortex</article-title>. <source/>J. Neuropathol. Exp. Neurol.
<volume>45</volume>, <fpage>222</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-198605000-00003</pub-id><pub-id pub-id-type="pmid">3958756</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Mahony</surname><given-names>S. M.</given-names></name><name><surname>Clarke</surname><given-names>G.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name></person-group> (<year>2017</year>). <article-title>Early-life adversity and brain development: is the microbiome a missing piece of the puzzle?</article-title>
<source/>Neuroscience
<volume>342</volume>, <fpage>37</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.09.068</pub-id><pub-id pub-id-type="pmid">26432952</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obermeier</surname><given-names>B.</given-names></name><name><surname>Daneman</surname><given-names>R.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Development, maintenance and disruption of the blood-brain barrier</article-title>. <source/>Nat. Med.
<volume>19</volume>, <fpage>1584</fpage>–<lpage>1596</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3407</pub-id><pub-id pub-id-type="pmid">24309662</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>J. C.</given-names></name><name><surname>Barker</surname><given-names>R.</given-names></name><name><surname>Kehoe</surname><given-names>P. G.</given-names></name><name><surname>Love</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β</article-title>. <source/>J. Alzheimers. Dis.
<volume>29</volume>, <fpage>853</fpage>–<lpage>861</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2012-111760</pub-id><pub-id pub-id-type="pmid">22330820</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardon</surname><given-names>M. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Lipopolysaccharide hyporesponsiveness: protective or damaging response to the brain?</article-title>
<source/>Rom. J. Morphol. Embryol.
<volume>56</volume>, <fpage>903</fpage>–<lpage>913</lpage>.<pub-id pub-id-type="pmid">26662122</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>M. M.</given-names></name><name><surname>Marso</surname><given-names>E.</given-names></name><name><surname>Pickett</surname><given-names>M. J.</given-names></name></person-group> (<year>1970</year>). <article-title>Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility</article-title>. <source/>Am. J. Clin. Pathol.
<volume>54</volume>, <fpage>178</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1093/ajcp/54.2.178</pub-id><pub-id pub-id-type="pmid">5453210</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Teeling</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration</article-title>. <source/>Semin. Immunopathol.
<volume>35</volume>, <fpage>601</fpage>–<lpage>612</lpage>. <pub-id pub-id-type="doi">10.1007/s00281-013-0382-8</pub-id><pub-id pub-id-type="pmid">23732506</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petkova</surname><given-names>S. B.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Factor</surname><given-names>S. M.</given-names></name><name><surname>Pestell</surname><given-names>R. G.</given-names></name><name><surname>Bouzahzah</surname><given-names>B.</given-names></name><name><surname>Jelicks</surname><given-names>L. A.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>The role of endothelin in the pathogenesis of Chagas' disease</article-title>. <source/>Int. J. Parasitol.
<volume>31</volume>, <fpage>499</fpage>–<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1016/S0020-7519(01)00168-0</pub-id><pub-id pub-id-type="pmid">11334935</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phares</surname><given-names>T. W.</given-names></name><name><surname>DiSano</surname><given-names>K. D.</given-names></name><name><surname>Hinton</surname><given-names>D. R.</given-names></name><name><surname>Hwang</surname><given-names>M.</given-names></name><name><surname>Zajac</surname><given-names>A. J.</given-names></name><name><surname>Stohlman</surname><given-names>S. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis</article-title>. <source/>J. Neuroimmunol.
<volume>263</volume>, <fpage>43</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2013.07.019</pub-id><pub-id pub-id-type="pmid">23992866</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccinini</surname><given-names>A. M.</given-names></name><name><surname>Midwood</surname><given-names>K. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Dampening inflammation by modulating TLR signalling</article-title>. <source/>Mediators Inflamm.
<volume>2010</volume>:<fpage>672395</fpage>. <pub-id pub-id-type="doi">10.1155/2010/672395</pub-id><pub-id pub-id-type="pmid">20706656</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilcher</surname><given-names>C. D.</given-names></name><name><surname>Shugars</surname><given-names>D. C.</given-names></name><name><surname>Fiscus</surname><given-names>S. A.</given-names></name><name><surname>Miller</surname><given-names>W. C.</given-names></name><name><surname>Menezes</surname><given-names>P.</given-names></name><name><surname>Giner</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health</article-title>. <source/>AIDS
<volume>15</volume>, <fpage>837</fpage>–<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1097/00002030-200105040-00004</pub-id><pub-id pub-id-type="pmid">11399956</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pottier</surname><given-names>C.</given-names></name><name><surname>Wallon</surname><given-names>D.</given-names></name><name><surname>Rousseau</surname><given-names>S.</given-names></name><name><surname>Rovelet-Lecrux</surname><given-names>A.</given-names></name><name><surname>Richard</surname><given-names>A. C.</given-names></name><name><surname>Rollin-Sillaire</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease</article-title>. <source/>J. Alzheimers. Dis.
<volume>35</volume>, <fpage>45</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-122311</pub-id><pub-id pub-id-type="pmid">23380991</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puntener</surname><given-names>U.</given-names></name><name><surname>Booth</surname><given-names>S. G.</given-names></name><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Teeling</surname><given-names>J. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia</article-title>. <source/>J. Neuroinflammation
<volume>9</volume>:<fpage>146</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-146</pub-id><pub-id pub-id-type="pmid">22738332</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Putignani</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Human gut microbiota: onset and shaping through life stages and perturbations</article-title>. <source/>Front. Cell. Infect. Microbiol.
<volume>2</volume>:<fpage>144</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2012.00144</pub-id><pub-id pub-id-type="pmid">23189272</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><name><surname>Brown</surname><given-names>M. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Innate immunity in the central nervous system</article-title>. <source/>J. Clin. Invest.
<volume>122</volume>, <fpage>1164</fpage>–<lpage>1171</lpage>. <pub-id pub-id-type="doi">10.1172/JCI58644</pub-id><pub-id pub-id-type="pmid">22466658</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><name><surname>Engelhardt</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>The anatomical and cellular basis of immune surveillance in the central nervous system</article-title>. <source/>Nat. Rev. Immunol.
<volume>12</volume>, <fpage>623</fpage>–<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1038/nri3265</pub-id><pub-id pub-id-type="pmid">22903150</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><name><surname>Perry</surname><given-names>V. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Microglial physiology: unique stimuli, specialized responses</article-title>. <source/>Annu. Rev. Immunol.
<volume>27</volume>, <fpage>119</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132528</pub-id><pub-id pub-id-type="pmid">19302036</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><name><surname>Schafer</surname><given-names>D.</given-names></name><name><surname>Vincent</surname><given-names>A.</given-names></name><name><surname>Blachere</surname><given-names>N. E.</given-names></name><name><surname>Bar-Or</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuroinflammation: ways in which the immune system affects the brain</article-title>. <source/>Neurotherapeutics
<volume>12</volume>, <fpage>896</fpage>–<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-015-0385-3</pub-id><pub-id pub-id-type="pmid">26306439</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rea</surname><given-names>K.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name></person-group> (<year>2016</year>). <article-title>The microbiome: a key regulator of stress and neuroinflammation</article-title>. <source/>Neurobiol. Stress
<volume>4</volume>, <fpage>23</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.ynstr.2016.03.001</pub-id><pub-id pub-id-type="pmid">27981187</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riviere</surname><given-names>G. R.</given-names></name><name><surname>Riviere</surname><given-names>K. H.</given-names></name><name><surname>Smith</surname><given-names>K. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease</article-title>. <source/>Oral Microbiol. Immunol.
<volume>17</volume>, <fpage>113</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1046/j.0902-0055.2001.00100.x</pub-id><pub-id pub-id-type="pmid">11929559</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roach</surname><given-names>T.</given-names></name><name><surname>Alcendor</surname><given-names>D. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Zika virus infection of cellular components of the blood-retinal barriers: implications for viral associated congenital ocular disease</article-title>. <source/>J. Neuroinflammation
<volume>14</volume>, <fpage>43</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-017-0824-7</pub-id><pub-id pub-id-type="pmid">28253931</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>A.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Ganesh</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>M. S.</given-names></name><name><surname>Lelutiu</surname><given-names>N.</given-names></name><name><surname>Gueorguieva</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Cyclooxygenase-2 in epilepsy</article-title>. <source/>Epilepsia
<volume>55</volume>, <fpage>17</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12461</pub-id><pub-id pub-id-type="pmid">24446952</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roosterman</surname><given-names>D.</given-names></name><name><surname>Goerge</surname><given-names>T.</given-names></name><name><surname>Schneider</surname><given-names>S. W.</given-names></name><name><surname>Bunnett</surname><given-names>N. W.</given-names></name><name><surname>Steinhoff</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Neuronal control of skin function: the skin as a neuroimmunoendocrine organ</article-title>. <source/>Physiol. Rev.
<volume>86</volume>, <fpage>1309</fpage>–<lpage>1379</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00026.2005</pub-id><pub-id pub-id-type="pmid">17015491</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosadini</surname><given-names>C. V.</given-names></name><name><surname>Kagan</surname><given-names>J. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Early innate immune responses to bacterial LPS</article-title>. <source/>Curr. Opin. Immunol.
<volume>44</volume>, <fpage>14</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2016.10.005</pub-id><pub-id pub-id-type="pmid">27842237</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>M. V.</given-names></name><name><surname>McGavern</surname><given-names>D. B.</given-names></name></person-group> (<year>2015</year>). <article-title>Immune surveillance of the cns following infection and injury</article-title>. <source/>Trends Immunol.
<volume>36</volume>, <fpage>637</fpage>–<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2015.08.002</pub-id><pub-id pub-id-type="pmid">26431941</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salmina</surname><given-names>A. B.</given-names></name><name><surname>Inzhutova</surname><given-names>A. I.</given-names></name><name><surname>Malinovskaya</surname><given-names>N. A.</given-names></name><name><surname>Petrova</surname><given-names>M. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: Neuronal and glial control</article-title>. <source/>J. Alzheimers Dis.
<volume>22</volume>, <fpage>17</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-091690</pub-id><pub-id pub-id-type="pmid">20847414</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampson</surname><given-names>T. R.</given-names></name><name><surname>Debelius</surname><given-names>J. W.</given-names></name><name><surname>Thron</surname><given-names>T.</given-names></name><name><surname>Janssen</surname><given-names>S.</given-names></name><name><surname>Shastri</surname><given-names>G. G.</given-names></name><name><surname>Ilhan</surname><given-names>Z. E.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease</article-title>. <source/>Cell
<volume>167</volume>, <fpage>1469.e1412</fpage>–<lpage>1480.e1412</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.11.018</pub-id><pub-id pub-id-type="pmid">27912057</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuel</surname><given-names>M. A.</given-names></name><name><surname>Diamond</surname><given-names>M. S.</given-names></name></person-group> (<year>2005</year>). <article-title>α/β interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival</article-title>. <source/>J. Virol.
<volume>79</volume>, <fpage>13350</fpage>–<lpage>13361</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.79.21.13350-13361.2005</pub-id><pub-id pub-id-type="pmid">16227257</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandor</surname><given-names>F.</given-names></name><name><surname>Buc</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Toll-like receptors. II. Distribution and pathways involved in TLR signalling</article-title>. <source/>Folia Biol. (Praha)
<volume>51</volume>, <fpage>188</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="pmid">16419614</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanes</surname><given-names>J. R.</given-names></name><name><surname>Lichtman</surname><given-names>J. W.</given-names></name></person-group> (<year>1999</year>). <article-title>Development of the vertebrate neuromuscular junction</article-title>. <source/>Annu. Rev. Neurosci.
<volume>22</volume>, <fpage>389</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.22.1.389</pub-id><pub-id pub-id-type="pmid">10202544</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoro</surname><given-names>M.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name><name><surname>Amici</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>). <article-title>New EMBO member's review: NF-κB and virus infection: who controls whom</article-title>. <source/>EMBO J.
<volume>22</volume>, <fpage>2552</fpage>–<lpage>2560</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/cdg267</pub-id><pub-id pub-id-type="pmid">12773372</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schacker</surname><given-names>T.</given-names></name><name><surname>Collier</surname><given-names>A. C.</given-names></name><name><surname>Hughes</surname><given-names>J.</given-names></name><name><surname>Shea</surname><given-names>T.</given-names></name><name><surname>Corey</surname><given-names>L.</given-names></name></person-group> (<year>1996</year>). <article-title>Clinical and epidemiologic features of primary HIV infection</article-title>. <source/>Ann. Intern. Med.
<volume>125</volume>, <fpage>257</fpage>–<lpage>264</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-125-4-199608150-00001</pub-id><pub-id pub-id-type="pmid">8678387</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>D. P.</given-names></name><name><surname>Stevens</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Phagocytic glial cells: Sculpting synaptic circuits in the developing nervous system</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>23</volume>, <fpage>1034</fpage>–<lpage>1040</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2013.09.012</pub-id><pub-id pub-id-type="pmid">24157239</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>D. P.</given-names></name><name><surname>Lehrman</surname><given-names>E. K.</given-names></name><name><surname>Kautzman</surname><given-names>A. G.</given-names></name><name><surname>Koyama</surname><given-names>R.</given-names></name><name><surname>Mardinly</surname><given-names>A. R.</given-names></name><name><surname>Yamasaki</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner</article-title>. <source/>Neuron
<volume>74</volume>, <fpage>691</fpage>–<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.026</pub-id><pub-id pub-id-type="pmid">22632727</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schinelli</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Pharmacology and physiopathology of the brain endothelin system: an overview</article-title>. <source/>Curr. Med. Chem.
<volume>13</volume>, <fpage>627</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.2174/092986706776055652</pub-id><pub-id pub-id-type="pmid">16529555</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>B. O.</given-names></name><name><surname>Backhed</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Signals from the gut microbiota to distant organs in physiology and disease</article-title>. <source/>Nat. Med.
<volume>22</volume>, <fpage>1079</fpage>–<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4185</pub-id><pub-id pub-id-type="pmid">27711063</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selkrig</surname><given-names>J.</given-names></name><name><surname>Wong</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Pettersson</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Metabolic tinkering by the gut microbiome: Implications for brain development and function</article-title>. <source/>Gut Microbes
<volume>5</volume>, <fpage>369</fpage>–<lpage>380</lpage>. <pub-id pub-id-type="doi">10.4161/gmic.28681</pub-id><pub-id pub-id-type="pmid">24685620</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>G.</given-names></name><name><surname>Sampson</surname><given-names>T. R.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name><name><surname>Mazmanian</surname><given-names>S. K.</given-names></name></person-group> (<year>2016</year>). <article-title>The central nervous system and the gut microbiome</article-title>. <source/>Cell
<volume>167</volume>, <fpage>915</fpage>–<lpage>932</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.027</pub-id><pub-id pub-id-type="pmid">27814521</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheen</surname><given-names>T. R.</given-names></name><name><surname>Ebrahimi</surname><given-names>C. M.</given-names></name><name><surname>Hiemstra</surname><given-names>I. H.</given-names></name><name><surname>Barlow</surname><given-names>S. B.</given-names></name><name><surname>Peschel</surname><given-names>A.</given-names></name><name><surname>Doran</surname><given-names>K. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Penetration of the blood-brain barrier by <italic>Staphylococcus aureus</italic>: contribution of membrane-anchored lipoteichoic acid</article-title>. <source/>J. Mol. Med.
<volume>88</volume>, <fpage>633</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-010-0630-5</pub-id><pub-id pub-id-type="pmid">20419283</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shima</surname><given-names>K.</given-names></name><name><surname>Kuhlenbaumer</surname><given-names>G.</given-names></name><name><surname>Rupp</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Chlamydia pneumoniae</italic> infection and Alzheimer's disease: a connection to remember?</article-title>
<source/>Med. Microbiol. Immunol.
<volume>199</volume>, <fpage>283</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1007/s00430-010-0162-1</pub-id><pub-id pub-id-type="pmid">20445987</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegenthaler</surname><given-names>J. A.</given-names></name><name><surname>Sohet</surname><given-names>F.</given-names></name><name><surname>Daneman</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>‘Sealing off the CNS’: cellular and molecular regulation of blood-brain barriergenesis</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>23</volume>, <fpage>1057</fpage>–<lpage>1064</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2013.06.006</pub-id><pub-id pub-id-type="pmid">23867075</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>V.</given-names></name><name><surname>Roth</surname><given-names>S.</given-names></name><name><surname>Llovera</surname><given-names>G.</given-names></name><name><surname>Sadler</surname><given-names>R.</given-names></name><name><surname>Garzetti</surname><given-names>D.</given-names></name><name><surname>Stecher</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Microbiota dysbiosis controls the neuroinflammatory response after stroke</article-title>. <source/>J. Neurosci.
<volume>36</volume>, <fpage>7428</fpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1114-16.2016</pub-id><pub-id pub-id-type="pmid">27413153</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skaper</surname><given-names>S. D.</given-names></name><name><surname>Giusti</surname><given-names>P.</given-names></name><name><surname>Facci</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Microglia and mast cells: two tracks on the road to neuroinflammation</article-title>. <source/>FASEB J.
<volume>26</volume>, <fpage>3103</fpage>–<lpage>3117</lpage>. <pub-id pub-id-type="doi">10.1096/fj.11-197194</pub-id><pub-id pub-id-type="pmid">22516295</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>E. E.</given-names></name><name><surname>Greenberg</surname><given-names>S. M.</given-names></name></person-group> (<year>2009</year>). <article-title>β-amyloid, blood vessels and brain function</article-title>. <source/>Stroke
<volume>40</volume>, <fpage>2601</fpage>–<lpage>2606</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.108.536839</pub-id><pub-id pub-id-type="pmid">19443808</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname><given-names>A.</given-names></name><name><surname>Hill</surname><given-names>M. D.</given-names></name><name><surname>Rahimi</surname><given-names>F.</given-names></name><name><surname>Warden</surname><given-names>L. A.</given-names></name><name><surname>Halliday</surname><given-names>G. M.</given-names></name><name><surname>Shepherd</surname><given-names>C. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease</article-title>. <source/>Brain Pathol.
<volume>19</volume>, <fpage>392</fpage>–<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3639.2008.00188.x</pub-id><pub-id pub-id-type="pmid">18637012</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname><given-names>C.</given-names></name><name><surname>Biber</surname><given-names>K.</given-names></name><name><surname>Michelucci</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Cellular and molecular characterization of microglia: a unique immune cell population</article-title>. <source/>Front. Immunol.
<volume>8</volume>:<fpage>198</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.00198</pub-id><pub-id pub-id-type="pmid">28303137</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speciale</surname><given-names>L.</given-names></name><name><surname>Roda</surname><given-names>K.</given-names></name><name><surname>Saresella</surname><given-names>M.</given-names></name><name><surname>Taramelli</surname><given-names>D.</given-names></name><name><surname>Ferrante</surname><given-names>P.</given-names></name></person-group> (<year>1998</year>). <article-title>Different endothelins stimulate cytokine production by peritoneal macrophages and microglial cell line</article-title>. <source/>Immunology
<volume>93</volume>, <fpage>109</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2567.1998.00391.x</pub-id><pub-id pub-id-type="pmid">9536126</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname><given-names>P.</given-names></name><name><surname>Condic</surname><given-names>M.</given-names></name><name><surname>Herrmann</surname><given-names>M.</given-names></name><name><surname>Oberstein</surname><given-names>T. J.</given-names></name><name><surname>Scharin-Mehlmann</surname><given-names>M.</given-names></name><name><surname>Gilbert</surname><given-names>D. F.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>32228</fpage>. <pub-id pub-id-type="doi">10.1038/srep32228</pub-id><pub-id pub-id-type="pmid">27624303</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stilling</surname><given-names>R. M.</given-names></name><name><surname>Bordenstein</surname><given-names>S. R.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Friends with social benefits: host-microbe interactions as a driver of brain evolution and development?</article-title>
<source/>Front. Cell. Infect. Microbiol.
<volume>4</volume>:<fpage>147</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2014.00147</pub-id><pub-id pub-id-type="pmid">25401092</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sukmawati</surname><given-names>D.</given-names></name><name><surname>Tanaka</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine</article-title>. <source/>Am. J. Transl. Res.
<volume>7</volume>, <fpage>411</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="pmid">26045883</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suter</surname><given-names>O.-C.</given-names></name><name><surname>Sunthorn</surname><given-names>T.</given-names></name><name><surname>Kraftsik</surname><given-names>R.</given-names></name><name><surname>Straubel</surname><given-names>J.</given-names></name><name><surname>Darekar</surname><given-names>P.</given-names></name><name><surname>Khalili</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease</article-title>. <source/>Stroke
<volume>33</volume>, <fpage>1986</fpage>. <pub-id pub-id-type="doi">10.1161/01.str.0000024523.82311.77</pub-id><pub-id pub-id-type="pmid">12154250</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarr</surname><given-names>A. J.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Reed</surname><given-names>N. S.</given-names></name><name><surname>Quan</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Kinetic characteristics of euflammation: the induction of controlled inflammation without overt sickness behavior</article-title>. <source/>Brain Behav. Immun.
<volume>42</volume>, <fpage>96</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2014.06.002</pub-id><pub-id pub-id-type="pmid">24929192</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teder</surname><given-names>P.</given-names></name><name><surname>Noble</surname><given-names>P. W.</given-names></name></person-group> (<year>2000</year>). <article-title>A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis</article-title>. <source/>Am. J. Respir. Cell Mol. Biol.
<volume>23</volume>, <fpage>7</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1165/ajrcmb.23.1.f192</pub-id><pub-id pub-id-type="pmid">10873147</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>T.</given-names></name><name><surname>Thomas</surname><given-names>G.</given-names></name><name><surname>McLendon</surname><given-names>C.</given-names></name><name><surname>Sutton</surname><given-names>T.</given-names></name><name><surname>Mullan</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>). <article-title>β-amyloid-mediated vasoactivity and vascular endothelial damage</article-title>. <source/>Nature
<volume>380</volume>, <fpage>168</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1038/380168a0</pub-id><pub-id pub-id-type="pmid">8600393</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tognini</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>Gut microbiota: a potential regulator of neurodevelopment</article-title>. <source/>Front. Cell. Neurosci.
<volume>11</volume>:<fpage>25</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2017.00025</pub-id><pub-id pub-id-type="pmid">28223922</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tohidpour</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>CagA-mediated pathogenesis of <italic>Helicobacter pylori</italic></article-title>. <source/>Microb. Pathog.
<volume>93</volume>, <fpage>44</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2016.01.005</pub-id><pub-id pub-id-type="pmid">26796299</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname><given-names>K. P.</given-names></name><name><surname>Obregon</surname><given-names>D.</given-names></name><name><surname>Quadros</surname><given-names>A.</given-names></name><name><surname>Patel</surname><given-names>N.</given-names></name><name><surname>Volmar</surname><given-names>C.</given-names></name><name><surname>Paris</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Proinflammatory and vasoactive effects of aβ in the cerebrovasculature</article-title>. <source/>Ann. N. Y. Acad. Sci.
<volume>977</volume>, <fpage>65</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2002.tb04799.x</pub-id><pub-id pub-id-type="pmid">12480734</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>T. T.</given-names></name><name><surname>Chen</surname><given-names>C. L.</given-names></name><name><surname>Lin</surname><given-names>Y. S.</given-names></name><name><surname>Chang</surname><given-names>C. P.</given-names></name><name><surname>Tsai</surname><given-names>C. C.</given-names></name><name><surname>Cheng</surname><given-names>Y. L.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Microglia retard Dengue virus-induced acute viral encephalitis</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>27670</fpage>. <pub-id pub-id-type="doi">10.1038/srep27670</pub-id><pub-id pub-id-type="pmid">27279150</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname><given-names>N.</given-names></name><name><surname>Guillemot</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>Neurogenesis in the embryonic and adult brain: same regulators, different roles</article-title>. <source/>Front. Cell. Neurosci.
<volume>8</volume>:<fpage>396</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00396</pub-id><pub-id pub-id-type="pmid">25505873</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Eldik</surname><given-names>L. J.</given-names></name><name><surname>Carrillo</surname><given-names>M. C.</given-names></name><name><surname>Cole</surname><given-names>P. E.</given-names></name><name><surname>Feuerbach</surname><given-names>D.</given-names></name><name><surname>Greenberg</surname><given-names>B. D.</given-names></name><name><surname>Hendrix</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>The roles of inflammation and immune mechanisms in Alzheimer's disease</article-title>. <source/>Alzheimers Dement. Transl. Res. Clin. Interven.
<volume>2</volume>, <fpage>99</fpage>–<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.trci.2016.05.001</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vercammen</surname><given-names>E.</given-names></name><name><surname>Staal</surname><given-names>J.</given-names></name><name><surname>Beyaert</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Sensing of viral infection and activation of innate immunity by toll-like receptor 3</article-title>. <source/>Clin. Microbiol. Rev.
<volume>21</volume>, <fpage>13</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00022-07</pub-id><pub-id pub-id-type="pmid">18202435</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Granata</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Brain inflammation in epilepsy: experimental and clinical evidence</article-title>. <source/>Epilepsia
<volume>46</volume>, <fpage>1724</fpage>–<lpage>1743</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2005.00298.x</pub-id><pub-id pub-id-type="pmid">16302852</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Fujinami</surname><given-names>R. S.</given-names></name><name><surname>White</surname><given-names>H. S.</given-names></name><name><surname>Preux</surname><given-names>P. M.</given-names></name><name><surname>Blumcke</surname><given-names>I.</given-names></name><name><surname>Sander</surname><given-names>J. W.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Infections, inflammation and epilepsy</article-title>. <source/>Acta Neuropathol.
<volume>131</volume>, <fpage>211</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-015-1481-5</pub-id><pub-id pub-id-type="pmid">26423537</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virgintino</surname><given-names>D.</given-names></name><name><surname>Girolamo</surname><given-names>F.</given-names></name><name><surname>Errede</surname><given-names>M.</given-names></name><name><surname>Capobianco</surname><given-names>C.</given-names></name><name><surname>Robertson</surname><given-names>D.</given-names></name><name><surname>Stallcup</surname><given-names>W. B.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis</article-title>. <source/>Angiogenesis
<volume>10</volume>, <fpage>35</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1007/s10456-006-9061-x</pub-id><pub-id pub-id-type="pmid">17225955</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>R.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name><name><surname>Ross</surname><given-names>R. P.</given-names></name><name><surname>Fitzgerald</surname><given-names>G. F.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Bacterial neuroactive compounds produced by psychobiotics</article-title>, in <source/>Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease, eds <person-group person-group-type="editor"><name><surname>Lyte</surname><given-names>M.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer New York</publisher-name>), <fpage>221</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-0897-4_10</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>S.</given-names></name><name><surname>Letiembre</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Heine</surname><given-names>H.</given-names></name><name><surname>Penke</surname><given-names>B.</given-names></name><name><surname>Hao</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease</article-title>. <source/>Cell. Physiol. Biochem.
<volume>20</volume>, <fpage>947</fpage>–<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1159/000110455</pub-id><pub-id pub-id-type="pmid">17982277</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.-Y.</given-names></name><name><surname>Tan</surname><given-names>M.-S.</given-names></name><name><surname>Yu</surname><given-names>J.-T.</given-names></name><name><surname>Tan</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease</article-title>. <source/>Ann. Transl. Med.
<volume>3</volume>, <fpage>136</fpage>. <pub-id pub-id-type="doi">10.3978/j.issn.2305-5839.2015.03.49</pub-id><pub-id pub-id-type="pmid">26207229</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.-L.</given-names></name><name><surname>Zeng</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>Y.-T.</given-names></name><name><surname>Liu</surname><given-names>Y.-J.</given-names></name><name><surname>Qiu</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title><italic>Helicobacter pylori</italic> filtrate impairs spatial learning and memory in rats and increases β-amyloid by enhancing expression of presenilin-2</article-title>. <source/>Front. Aging Neurosci.
<volume>6</volume>:<fpage>66</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2014.00066</pub-id><pub-id pub-id-type="pmid">24782763</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weidenfeller</surname><given-names>C.</given-names></name><name><surname>Svendsen</surname><given-names>C. N.</given-names></name><name><surname>Shusta</surname><given-names>E. V.</given-names></name></person-group> (<year>2007</year>). <article-title>Differentiating embryonic neural progenitor cells induce blood-brain barrier properties</article-title>. <source/>J. Neurochem.
<volume>101</volume>, <fpage>555</fpage>–<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04394.x</pub-id><pub-id pub-id-type="pmid">17254017</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welling</surname><given-names>M. M.</given-names></name><name><surname>Nabuurs</surname><given-names>R. J. A.</given-names></name><name><surname>van der Weerd</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Potential role of antimicrobial peptides in the early onset of Alzheimer's disease</article-title>. <source/>Alzheimers Dement. J. Alzheimers Assoc.
<volume>11</volume>, <fpage>51</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2013.12.020</pub-id><pub-id pub-id-type="pmid">24637300</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>C.</given-names></name><name><surname>Engelhard</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Pathophysiology of traumatic brain injury</article-title>. <source/>Br. J. Anaesth.
<volume>99</volume>, <fpage>4</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/bja/aem131</pub-id><pub-id pub-id-type="pmid">17573392</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodcock</surname><given-names>T.</given-names></name><name><surname>Morganti-Kossmann</surname><given-names>M. C.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of markers of inflammation in traumatic brain injury</article-title>. <source/>Front. Neurol.
<volume>4</volume>:<fpage>18</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2013.00018</pub-id><pub-id pub-id-type="pmid">23459929</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wozniak</surname><given-names>M. A.</given-names></name><name><surname>Shipley</surname><given-names>S. J.</given-names></name><name><surname>Combrinck</surname><given-names>M.</given-names></name><name><surname>Wilcock</surname><given-names>G. K.</given-names></name><name><surname>Itzhaki</surname><given-names>R. F.</given-names></name></person-group> (<year>2005</year>). <article-title>Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients</article-title>. <source/>J. Med. Virol.
<volume>75</volume>, <fpage>300</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.20271</pub-id><pub-id pub-id-type="pmid">15602731</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xanthos</surname><given-names>D. N.</given-names></name><name><surname>Sandkuhler</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity</article-title>. <source/>Nat. Rev. Neurosci.
<volume>15</volume>, <fpage>43</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3617</pub-id><pub-id pub-id-type="pmid">24281245</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J. S.</given-names></name><name><surname>Ramanathan</surname><given-names>M. P.</given-names></name><name><surname>Muthumani</surname><given-names>K.</given-names></name><name><surname>Choo</surname><given-names>A. Y.</given-names></name><name><surname>Jin</surname><given-names>S. H.</given-names></name><name><surname>Yu</surname><given-names>Q. C.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Induction of inflammation by West Nile virus capsid through the Caspase-9 apoptotic pathway</article-title>. <source/>Emerg. Infect. Dis.
<volume>8</volume>, <fpage>1379</fpage>–<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.3201/eid0812.020224</pub-id><pub-id pub-id-type="pmid">12498651</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Yeung</surname><given-names>P. K. K.</given-names></name><name><surname>McAlonan</surname><given-names>G. M.</given-names></name><name><surname>Chung</surname><given-names>S. S. M.</given-names></name><name><surname>Chung</surname><given-names>S. K.</given-names></name></person-group> (<year>2013</year>). <article-title>Transgenic mice over-expressing endothelial endothelin-1 show cognitive deficit with blood–brain barrier breakdown after transient ischemia with long-term reperfusion</article-title>. <source/>Neurobiol. Learn. Mem.
<volume>101</volume>, <fpage>46</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2013.01.002</pub-id><pub-id pub-id-type="pmid">23313614</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Lapointe</surname><given-names>B. M.</given-names></name><name><surname>Clark</surname><given-names>S. R.</given-names></name><name><surname>Zbytnuik</surname><given-names>L.</given-names></name><name><surname>Kubes</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide</article-title>. <source/>J. Immunol.
<volume>177</volume>, <fpage>8103</fpage>–<lpage>8110</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.177.11.8103</pub-id><pub-id pub-id-type="pmid">17114485</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zochodne</surname><given-names>D. W.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>X. Q.</given-names></name></person-group> (<year>2001</year>). <article-title>Evidence that nitric oxide- and opioid-containing interneurons innervate vessels in the dorsal horn of the spinal cord of rats</article-title>. <source/>J. Physiol. (Lond).
<volume>532</volume>, <fpage>749</fpage>–<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.2001.0749e.x</pub-id><pub-id pub-id-type="pmid">11313443</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>